age,sex,hospdead,dzgroup,edu,income,charges,race,ca,prg2m,prg6m,dnr,dnrday,meanbp,wblc,hrt,resp,temp,pafi,alb,bili,crea,sod,ph,glucose,bun,urine,adlp,adls,sfdm2,adlsc
62.84998,male,0.0,Lung Cancer,11.0,$11-$25k,9715.0,other,metastatic,0.5,0.25,no dnr,5.0,97.0,6.0,69.0,22.0,36.0,388.0,1.7998047,0.19998169,1.19995117,141.0,7.459961,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
60.33899,female,1.0,Cirrhosis,12.0,$11-$25k,34496.0,white,no,0.0,0.0,no dnr,9.0,43.0,17.0976562,112.0,34.0,34.59375,98.0,2.8999023,0.89990234,5.5,132.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
52.74698,female,0.0,Cirrhosis,12.0,under $11k,41094.0,white,no,0.75,0.5,no dnr,17.0,70.0,8.5,88.0,28.0,37.39844,231.65625,2.8999023,2.19970703,2.0,134.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
42.38498,female,0.0,Lung Cancer,11.0,under $11k,3075.0,white,metastatic,0.899999619,0.5,no dnr,3.0,75.0,9.09960938,88.0,32.0,35.0,224.0,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.88495,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,50127.0,white,no,0.899999619,0.8999996,no dnr,16.0,59.0,13.5,112.0,20.0,37.89844,173.3125,2.8999023,0.89990234,0.79992676,143.0,7.509766,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
93.01599,male,1.0,Coma,14.0,under $11k,6884.0,white,no,0.0,0.0,no dnr,4.0,110.0,10.3984375,101.0,44.0,38.39844,266.625,2.8999023,0.89990234,0.69995117,140.0,7.65918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
62.37097,male,0.0,CHF,14.0,$25-$50k,30460.0,white,no,0.699999809,0.6999998,no dnr,9.0,78.0,11.6992188,120.0,28.0,37.39844,309.5,4.7998047,0.39996338,1.59985352,132.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
86.83899,male,0.0,CHF,12.0,under $11k,30460.0,white,no,0.799999714,0.3999999,no dnr,7.0,72.0,13.5996094,100.0,26.0,37.59375,404.75,2.8999023,0.89990234,2.0,139.0,7.509766,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
85.65594,male,0.0,Lung Cancer,12.0,under $11k,25024.0,black,metastatic,0.049999982,0.0001249999,dnr after sadm,2.0,97.0,9.69921875,56.0,20.0,36.59375,357.125,2.8999023,0.39996338,1.0,143.0,7.449219,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
42.25897,female,0.0,Colon Cancer,11.0,$25-$50k,9914.0,hispanic,metastatic,0.699999809,0.5,no dnr,8.0,84.0,11.2988281,94.0,20.0,38.19531,224.0,4.6992188,0.19998169,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
47.94498,male,0.0,CHF,12.0,under $11k,15558.0,white,no,0.699999809,0.5,no dnr,7.0,70.0,10.8984375,105.0,24.0,36.5,224.0,4.1992188,0.5,1.0,134.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.0
59.20099,male,1.0,Lung Cancer,14.0,under $11k,29388.0,white,metastatic,0.699999809,0.5,dnr after sadm,12.0,77.0,10.7988281,90.0,22.0,36.39844,224.0,2.8999023,0.89990234,1.09985352,136.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
29.002,female,0.0,Cirrhosis,16.0,$11-$25k,4353.0,white,no,0.699999809,0.5,no dnr,4.0,56.0,5.5,56.0,20.0,37.19531,224.0,2.8999023,6.09960938,0.69995117,130.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
68.14197,male,0.0,CHF,12.0,$11-$25k,19783.0,white,no,0.899999619,0.6999998,no dnr,8.0,68.0,9.3984375,80.0,22.0,36.0,224.0,2.8999023,0.59997559,2.59960938,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
43.53998,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,706577.0,white,no,0.899999619,0.8999996,no dnr,115.0,67.0,24.5976562,172.0,20.0,38.79688,113.32812,2.8999023,0.89990234,0.59997559,134.0,7.399414,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.7641602
58.823,female,0.0,Lung Cancer,12.0,>$50k,10758.0,white,metastatic,0.899999619,0.6999998,no dnr,7.0,97.0,15.8984375,92.0,20.0,37.19531,224.0,4.2998047,0.19998169,0.79992676,134.0,7.419922,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
45.418,male,0.0,Lung Cancer,12.0,under $11k,8400.0,white,metastatic,0.699999809,0.5,no dnr,7.0,97.0,10.7988281,100.0,24.0,37.29688,585.125,2.8999023,0.29998779,1.09985352,137.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3515625
63.66299,female,1.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,283303.0,white,no,0.099999964,0.0009999992,dnr after sadm,12.0,69.0,30.0976562,108.0,22.0,36.69531,155.53125,2.8999023,14.0,2.89990234,130.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.84399,male,1.0,Cirrhosis,16.0,under $11k,27985.0,white,no,0.699999809,0.5,dnr after sadm,12.0,83.0,5.0,100.0,24.0,37.39844,224.0,1.6999512,12.7988281,0.29998779,122.0,7.419922,135.0,23.0,1968.0,7.0,7.0,<2 mo. follow-up,7.0
55.13797,male,0.0,CHF,8.0,$11-$25k,18191.0,hispanic,no,0.5,0.5,no dnr,10.0,78.0,10.5996094,72.0,20.0,36.0,224.0,2.8999023,0.89990234,1.5,134.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),2.5110989
68.25494,male,0.0,Lung Cancer,13.0,>$50k,10755.0,white,metastatic,0.899999619,0.6999998,no dnr,7.0,91.0,5.0,92.0,20.0,36.5,224.0,4.2998047,0.29998779,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
48.70398,male,0.0,Lung Cancer,16.0,under $11k,55384.0,other,metastatic,0.5,0.125,dnr after sadm,11.0,66.0,12.5,125.0,30.0,37.0,170.0,2.8999023,0.89990234,1.0,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2636719
49.61298,female,0.0,ARF/MOSF w/Sepsis,12.0,$25-$50k,542266.0,white,no,0.599999905,0.5,no dnr,50.0,67.0,11.0,120.0,48.0,38.89844,200.0,2.0,4.09960938,0.59997559,130.0,7.399414,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
50.724,female,0.0,Lung Cancer,12.0,$25-$50k,4913.0,asian,metastatic,1.0,1.0,no dnr,3.0,71.0,9.79882812,88.0,24.0,37.39844,224.0,2.8999023,0.89990234,0.89990234,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.065918
29.36099,female,0.0,Colon Cancer,17.0,$25-$50k,7792.0,white,metastatic,0.5,0.09999996,no dnr,4.0,96.0,10.5996094,112.0,20.0,37.0,224.0,3.699707,1.39990234,0.59997559,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8149414
53.84,male,0.0,COPD,12.0,under $11k,9871.0,white,no,0.899999619,0.5999999,dnr after sadm,4.0,134.0,7.79980469,106.0,22.0,37.89844,304.125,3.7998047,0.5,0.79992676,141.0,7.379883,135.0,23.0,1968.0,5.0,4.0,no(M2 and SIP pres),4.0
82.41498,female,1.0,Lung Cancer,12.0,under $11k,7212.0,white,metastatic,0.699999809,0.5,dnr before sadm,-1.0,75.0,6.79980469,114.0,20.0,37.19531,224.0,3.0996094,0.89990234,1.79980469,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7041016
27.32399,male,1.0,MOSF w/Malig,19.0,under $11k,160060.0,asian,yes,0.049999982,0.0001249999,dnr after sadm,5.0,77.0,0.09999084,144.0,36.0,38.89844,45.0,2.3999023,5.0,1.39990234,147.0,7.30957,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
30.10799,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,57611.0,asian,no,0.699999809,0.5,no dnr,10.0,92.0,8.79882812,112.0,27.0,37.59375,225.0,2.8999023,0.89990234,0.39996338,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8461914
50.37097,male,0.0,Cirrhosis,16.0,$11-$25k,465380.0,white,no,0.699999809,0.5,no dnr,105.0,98.0,8.3984375,82.0,20.0,37.39844,197.5,3.0,6.79980469,0.69995117,138.0,7.319336,135.0,23.0,1968.0,3.0,1.0,SIP>=30,1.0
74.48297,male,0.0,CHF,16.0,>$50k,18134.0,white,no,0.949999809,0.5999999,no dnr,15.0,111.0,6.89941406,60.0,32.0,36.79688,224.0,3.7998047,0.59997559,1.59985352,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
55.73199,male,0.0,Cirrhosis,8.0,under $11k,52092.0,hispanic,no,0.899999619,0.8999996,no dnr,13.0,121.0,19.6992188,118.0,18.0,37.39844,404.75,2.199707,0.89990234,0.79992676,117.0,7.379883,135.0,23.0,1968.0,7.0,6.0,SIP>=30,6.0
77.21295,female,0.0,COPD,0.0,under $11k,9078.0,hispanic,no,0.75,0.75,dnr after sadm,2.0,113.0,8.29882812,93.0,25.0,36.19531,250.0,2.8999023,0.89990234,2.09960938,145.0,7.269531,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
61.02399,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,109627.0,white,no,0.599999905,0.5999999,dnr after sadm,17.0,80.0,15.3984375,128.0,30.0,38.5,217.5,2.2998047,0.39996338,2.39990234,143.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8251953
56.48999,female,0.0,CHF,12.0,under $11k,38548.0,hispanic,no,0.699999809,0.5,no dnr,5.0,38.0,10.5996094,92.0,20.0,36.0,224.0,2.8999023,0.89990234,6.0,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0981445
57.53299,female,0.0,Cirrhosis,14.0,under $11k,156556.0,hispanic,no,0.699999809,0.5,no dnr,28.0,77.0,12.1992188,92.0,18.0,37.59375,552.375,2.5,23.5976562,0.89990234,132.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1318359
68.98596,female,0.0,COPD,10.0,under $11k,5763.0,white,no,0.989999771,0.9499998,no dnr,4.0,76.0,10.5996094,78.0,26.0,36.59375,280.9375,4.0,0.89990234,0.79992676,142.0,7.359375,135.0,23.0,1968.0,1.0,0.0,SIP>=30,0.0
41.97897,male,0.0,CHF,14.0,$11-$25k,5552.0,white,no,0.699999809,0.5,no dnr,6.0,120.0,8.3984375,86.0,22.0,37.5,295.1875,2.8999023,0.89990234,1.79980469,129.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
19.79199,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,167971.0,black,no,0.899999619,0.75,no dnr,33.0,83.0,9.59960938,52.0,6.0,39.0,310.0,2.8999023,0.89990234,1.19995117,131.0,7.439453,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
57.50897,female,0.0,CHF,14.0,under $11k,6403.0,black,no,1.0,1.0,no dnr,4.0,83.0,14.2988281,106.0,24.0,36.79688,280.9375,2.8999023,0.89990234,2.29980469,138.0,7.449219,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
73.40698,male,0.0,Colon Cancer,12.0,under $11k,22934.0,white,metastatic,0.899999619,0.3999999,no dnr,9.0,71.0,16.5,76.0,10.0,37.0,224.0,4.0,0.59997559,0.79992676,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4677734
68.31799,male,0.0,Colon Cancer,21.0,>$50k,9205.0,white,metastatic,0.699999809,0.5,no dnr,6.0,89.0,10.5996094,92.0,18.0,39.0,224.0,2.8999023,0.5,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.79498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,271250.0,white,no,0.699999809,0.5,dnr after sadm,21.0,59.0,30.5976562,90.0,22.0,37.5,70.90625,1.8999023,5.39941406,2.69970703,128.0,7.329102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6855469
45.71899,male,0.0,CHF,12.0,under $11k,115112.0,white,no,0.899999619,0.5,no dnr,20.0,57.0,12.2988281,96.0,22.0,36.0,185.0,3.8999023,0.89990234,1.39990234,135.0,7.599609,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.48798,male,0.0,CHF,16.0,under $11k,120920.0,hispanic,no,0.5,0.5,dnr after sadm,16.0,62.0,21.796875,102.0,24.0,36.59375,415.0,2.8999023,0.89990234,4.0,124.0,7.429688,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
74.995,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,348931.0,white,no,0.699999809,0.5,dnr after sadm,23.0,50.0,51.1953125,120.0,18.0,36.19531,237.5,2.8999023,1.0,4.79980469,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4423828
56.19397,male,1.0,ARF/MOSF w/Sepsis,6.0,under $11k,230733.0,other,no,0.699999809,0.5,dnr after sadm,20.0,68.0,26.6992188,130.0,28.0,38.5,121.65625,1.6999512,3.89990234,2.09960938,131.0,7.449219,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
44.849,female,0.0,MOSF w/Malig,10.0,$11-$25k,25176.0,hispanic,yes,0.599999905,0.3999999,no dnr,12.0,91.0,4.69921875,70.0,32.0,37.09375,447.5625,2.2998047,7.0,0.79992676,136.0,7.359375,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
51.09698,female,0.0,CHF,11.0,under $11k,30877.0,black,no,0.949999809,0.9499998,no dnr,19.0,100.0,5.69921875,120.0,32.0,37.59375,203.6875,4.1992188,0.19998169,4.0,140.0,7.459961,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
36.30899,male,0.0,CHF,16.0,under $11k,23476.0,white,no,0.599999905,0.5,no dnr,11.0,64.0,6.79980469,115.0,20.0,36.29688,224.0,4.3994141,4.5,1.29980469,121.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
76.25696,male,0.0,CHF,12.0,under $11k,14926.0,white,no,0.899999619,0.75,no dnr,9.0,74.0,9.29882812,96.0,30.0,36.39844,266.625,2.8999023,1.09985352,1.19995117,141.0,7.399414,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
51.30499,male,0.0,CHF,12.0,under $11k,52187.0,black,no,0.799999714,0.75,no dnr,25.0,71.0,10.5996094,104.0,18.0,36.5,224.0,2.8999023,0.89990234,2.39990234,128.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
74.54297,female,0.0,COPD,12.0,under $11k,9631.0,white,no,0.699999809,0.5,no dnr,7.0,83.0,14.1992188,92.0,22.0,36.39844,164.0,3.2998047,0.29998779,0.79992676,137.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.30798,male,0.0,Lung Cancer,17.0,$25-$50k,29939.0,white,metastatic,1.0,1.0,no dnr,12.0,95.0,11.5996094,108.0,22.0,38.0,183.0,2.8999023,0.89990234,0.79992676,136.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.57697,female,0.0,CHF,12.0,under $11k,3124.0,other,no,0.699999809,0.5,no dnr,3.0,90.0,12.3984375,84.0,32.0,36.59375,276.1875,2.8999023,0.89990234,0.79992676,139.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3085938
84.95795,male,0.0,CHF,14.0,>$50k,30942.0,white,no,0.949999809,0.8499999,no dnr,17.0,92.0,13.6992188,80.0,32.0,37.19531,313.3125,3.7998047,0.29998779,1.29980469,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.52197,male,1.0,MOSF w/Malig,18.0,>$50k,320843.0,white,yes,0.099999964,0.0009999992,no dnr,21.0,66.0,0.19998169,130.0,18.0,37.5,315.0,1.8999023,3.79980469,7.29980469,134.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.685,female,0.0,ARF/MOSF w/Sepsis,22.0,$25-$50k,220639.0,white,no,0.599999905,0.5999999,no dnr,35.0,62.0,36.6953125,125.0,24.0,39.19531,208.5625,1.5998535,0.39996338,7.69921875,139.0,7.399414,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.55896,female,1.0,COPD,12.0,under $11k,4894.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,123.0,13.2988281,98.0,32.0,37.19531,144.875,2.8999023,0.89990234,0.5,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
60.10098,male,0.0,Cirrhosis,12.0,under $11k,63466.0,white,no,0.699999809,0.5,no dnr,15.0,110.0,6.29980469,125.0,10.0,38.09375,208.0,2.7998047,3.39990234,1.0,142.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3813477
70.81195,male,0.0,CHF,12.0,under $11k,6254.0,black,no,0.899999619,0.7999997,no dnr,8.0,88.0,6.89941406,80.0,22.0,37.0,224.0,2.8999023,0.89990234,1.79980469,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5957031
30.76199,male,0.0,CHF,10.0,under $11k,8437.0,hispanic,no,0.799999714,0.6999998,no dnr,6.0,70.0,6.59960938,122.0,16.0,36.5,528.5,2.8999023,0.89990234,2.09960938,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.23798,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,321716.0,white,no,0.899999619,0.8999996,no dnr,61.0,68.0,9.5,122.0,12.0,38.69531,114.0,2.8999023,0.89990234,1.29980469,136.0,7.319336,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
51.70999,male,0.0,CHF,12.0,under $11k,31222.0,asian,no,0.799999714,0.1999999,no dnr,12.0,50.0,6.69921875,75.0,20.0,36.79688,224.0,3.699707,0.89990234,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.64294,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,180786.0,white,no,0.699999809,0.5,no dnr,17.0,68.0,13.2988281,92.0,38.0,38.79688,113.67188,3.3999023,1.09985352,2.29980469,133.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
69.41498,male,0.0,Lung Cancer,16.0,$25-$50k,8706.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,109.0,5.29980469,68.0,20.0,36.89844,224.0,2.699707,0.89990234,0.69995117,133.0,7.419922,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
57.19098,male,0.0,CHF,12.0,$11-$25k,28476.0,white,no,0.299999952,0.09999996,no dnr,9.0,59.0,16.0,85.0,26.0,36.79688,204.75,2.8999023,0.5,0.79992676,126.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
37.73297,male,0.0,CHF,12.0,$25-$50k,26278.0,white,no,0.199999928,0.04999998,no dnr,9.0,67.0,7.5,130.0,16.0,36.5,347.5625,3.0,0.59997559,0.89990234,132.0,7.469727,135.0,23.0,1968.0,5.0,7.0,<2 mo. follow-up,7.0
44.05499,female,0.0,Colon Cancer,16.0,>$50k,18563.0,white,metastatic,1.0,0.6999998,no dnr,7.0,85.0,8.5,72.0,20.0,37.39844,224.0,2.8999023,0.89990234,1.19995117,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
72.15594,male,0.0,ARF/MOSF w/Sepsis,12.0,>$50k,187014.0,white,no,0.799999714,0.7999997,no dnr,35.0,75.0,17.296875,120.0,24.0,38.29688,257.5,2.5996094,4.89941406,0.69995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.7045898
45.56598,male,1.0,MOSF w/Malig,18.0,$25-$50k,181701.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,0.29998779,140.0,33.0,38.5,129.0,2.2998047,31.3984375,4.79980469,142.0,7.359375,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
41.95999,male,0.0,Lung Cancer,16.0,>$50k,4173.0,white,metastatic,0.949999809,0.7999997,no dnr,4.0,97.0,10.7988281,88.0,20.0,36.39844,380.9375,3.7998047,0.5,1.09985352,133.0,7.479492,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1796875
59.31,male,0.0,ARF/MOSF w/Sepsis,15.0,>$50k,538692.0,white,no,0.5,0.3999999,no dnr,72.0,60.0,19.3984375,160.0,38.0,37.29688,113.32812,3.0996094,13.0996094,1.29980469,142.0,7.509766,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
45.61499,female,1.0,Cirrhosis,16.0,>$50k,302353.0,white,no,0.299999952,0.25,dnr after sadm,41.0,57.0,13.5996094,112.0,28.0,38.59375,134.4375,1.6999512,1.5,0.89990234,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5454102
65.98499,female,0.0,Colon Cancer,12.0,under $11k,18980.0,hispanic,metastatic,0.699999809,0.5,no dnr,10.0,127.0,17.796875,96.0,26.0,38.89844,372.0,4.0996094,0.29998779,0.79992676,140.0,7.399414,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
95.79199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,74764.0,white,no,0.699999809,0.5,dnr after sadm,16.0,88.0,11.5996094,65.0,8.0,37.19531,360.0,2.5996094,0.89990234,1.69995117,147.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.9414062
76.59094,male,0.0,Colon Cancer,17.0,$11-$25k,7137.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,83.0,12.7988281,76.0,18.0,38.29688,390.4375,4.0996094,0.79992676,0.79992676,146.0,7.439453,135.0,23.0,1968.0,1.0,2.0,<2 mo. follow-up,2.0
68.10095,male,0.0,CHF,12.0,$11-$25k,9586.0,white,no,0.899999619,0.6999998,no dnr,4.0,72.0,5.89941406,80.0,18.0,36.79688,224.0,2.8999023,0.89990234,2.19970703,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.9719238
78.85297,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,39420.0,white,no,0.699999809,0.5,dnr after sadm,4.0,60.0,36.1953125,112.0,11.0,36.59375,214.28125,2.8999023,1.09985352,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.9472656
37.87,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,397017.0,white,no,0.099999964,0.0009999992,no dnr,120.0,83.0,23.5,122.0,26.0,37.59375,257.5,2.8999023,3.09960938,5.19921875,134.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5400391
74.90997,female,0.0,COPD,16.0,under $11k,8166.0,white,no,0.799999714,0.6999998,no dnr,6.0,106.0,11.3984375,84.0,22.0,37.0,424.0,2.8999023,0.89990234,0.79992676,142.0,7.399414,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
31.702,female,0.0,Cirrhosis,14.0,under $11k,231119.0,black,no,0.199999928,0.09999996,no dnr,49.0,77.0,7.69921875,80.0,20.0,37.19531,490.4375,2.199707,2.69970703,1.39990234,127.0,7.489258,135.0,23.0,1968.0,6.0,1.0,SIP>=30,1.0
54.93997,female,0.0,CHF,14.0,$11-$25k,27561.0,white,no,0.699999809,0.5,no dnr,10.0,55.0,6.19921875,104.0,24.0,36.79688,504.0,3.5996094,1.09985352,0.79992676,136.0,7.459961,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
43.30197,male,1.0,Cirrhosis,14.0,under $11k,283145.0,hispanic,no,0.699999809,0.5,no dnr,39.0,83.0,10.0,80.0,20.0,37.0,224.0,2.0996094,13.0,1.0,130.0,7.419922,135.0,23.0,1968.0,3.0,2.0,<2 mo. follow-up,2.0
54.92999,female,0.0,Lung Cancer,12.0,$25-$50k,15392.0,asian,metastatic,0.699999809,0.5,no dnr,8.0,143.0,10.6992188,84.0,40.0,36.19531,224.0,3.2998047,0.89990234,0.79992676,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
70.21497,male,0.0,Colon Cancer,12.0,$11-$25k,8442.0,white,metastatic,0.899999619,0.5,no dnr,7.0,117.0,10.1992188,22.0,18.0,38.0,224.0,3.0996094,0.69995117,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.09399,female,0.0,Cirrhosis,3.0,under $11k,71992.0,black,no,0.699999809,0.5,dnr after sadm,5.0,104.0,21.796875,82.0,20.0,37.0,224.0,2.0,6.59960938,0.59997559,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.05096,male,0.0,Cirrhosis,14.0,$25-$50k,14944.0,white,no,0.699999809,0.5,no dnr,10.0,77.0,12.0996094,72.0,22.0,36.39844,224.0,2.5,21.6992188,1.19995117,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
69.34698,male,1.0,MOSF w/Malig,18.0,under $11k,433684.0,asian,metastatic,0.699999809,0.5,no dnr,42.0,112.0,10.3984375,125.0,14.0,36.5,274.25,3.7998047,5.69921875,1.09985352,140.0,7.449219,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
64.98798,female,0.0,Lung Cancer,12.0,under $11k,8137.0,white,metastatic,0.699999809,0.5,no dnr,4.0,110.0,18.796875,80.0,20.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1987305
80.62097,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,104163.0,white,no,0.699999809,0.5,dnr after sadm,2.0,61.0,23.0,140.0,32.0,39.19531,75.54688,2.2998047,1.5,1.89990234,135.0,7.129883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3618164
72.172,male,1.0,Lung Cancer,12.0,under $11k,62158.0,white,metastatic,0.5,0.25,no dnr,12.0,63.0,5.09960938,140.0,36.0,36.5,176.65625,2.699707,0.89990234,1.09985352,135.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
53.06198,male,0.0,COPD,12.0,under $11k,6734.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,77.0,10.8984375,72.0,24.0,36.39844,280.9375,3.8999023,0.89990234,0.79992676,126.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6191406
52.50699,female,1.0,CHF,12.0,$11-$25k,20735.0,white,no,0.599999905,0.1999999,dnr after sadm,6.0,67.0,8.5,88.0,20.0,36.59375,224.0,3.0996094,0.69995117,1.39990234,129.0,7.419922,135.0,23.0,1968.0,6.0,7.0,<2 mo. follow-up,7.0
74.97095,male,0.0,Colon Cancer,12.0,under $11k,43009.0,white,metastatic,0.899999619,0.8499999,no dnr,19.0,91.0,6.79980469,88.0,20.0,36.79688,224.0,4.5996094,2.5,1.09985352,142.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9162598
53.34998,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,483991.0,asian,no,0.5,0.1999999,no dnr,52.0,73.0,19.5,158.0,36.0,39.29688,187.5,3.5996094,11.0996094,2.69970703,154.0,7.369141,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
89.58795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,19238.0,white,metastatic,0.699999809,0.5,no dnr,4.0,33.0,13.6992188,0.0,0.0,38.5,122.0,2.2998047,0.5,1.0,130.0,7.289062,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.5683594
56.62399,male,0.0,Colon Cancer,12.0,>$50k,27408.0,white,metastatic,0.699999809,0.5,no dnr,11.0,116.0,8.19921875,102.0,18.0,38.39844,224.0,4.2998047,0.29998779,1.19995117,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
75.04199,male,0.0,Colon Cancer,16.0,under $11k,8723.0,hispanic,metastatic,0.699999809,0.5,no dnr,6.0,123.0,16.296875,112.0,28.0,36.0,352.375,2.8999023,1.69995117,7.59960938,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,2.2495117
75.76196,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,74162.0,white,no,0.799999714,0.7999997,no dnr,21.0,68.0,16.5976562,79.0,20.0,37.19531,132.71875,2.8999023,0.89990234,1.09985352,132.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
32.99899,female,1.0,Cirrhosis,19.0,$25-$50k,88720.0,other,no,0.0,0.0,dnr after sadm,10.0,62.0,11.5996094,130.0,8.0,36.59375,296.625,2.0,31.0,4.19921875,127.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
72.39697,female,0.0,CHF,10.0,under $11k,11588.0,black,no,0.699999809,0.5,no dnr,4.0,115.0,6.59960938,104.0,20.0,37.29688,460.0,2.8999023,0.89990234,2.29980469,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
66.5,male,0.0,CHF,10.0,under $11k,29870.0,white,no,0.25,0.75,no dnr,12.0,85.0,10.8984375,88.0,16.0,36.39844,224.0,2.8999023,0.89990234,2.29980469,133.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
72.78296,male,0.0,CHF,13.0,under $11k,45798.0,white,no,0.799999714,0.75,no dnr,24.0,65.0,13.5,105.0,26.0,39.0,132.5,2.8999023,0.5,1.69995117,139.0,7.519531,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
61.56897,female,0.0,CHF,8.0,under $11k,22040.0,white,no,1.0,0.8999996,no dnr,11.0,90.0,6.5,80.0,20.0,36.0,224.0,4.6992188,1.09985352,1.69995117,134.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
52.43298,female,0.0,Colon Cancer,16.0,$11-$25k,12161.0,black,metastatic,0.699999809,0.5,dnr after sadm,3.0,89.0,7.89941406,46.0,20.0,36.79688,224.0,2.8999023,0.39996338,0.89990234,140.0,7.419922,135.0,23.0,1968.0,2.0,2.0,<2 mo. follow-up,2.0
66.93195,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,88469.0,black,yes,0.949999809,0.8499999,no dnr,17.0,141.0,22.296875,148.0,28.0,37.5,256.625,2.199707,0.79992676,1.09985352,142.0,7.459961,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
84.76697,female,0.0,COPD,16.0,under $11k,19608.0,white,no,0.5,0.3999999,no dnr,8.0,70.0,11.5,75.0,50.0,36.5,200.0,2.8999023,0.89990234,0.79992676,138.0,7.429688,135.0,23.0,1968.0,1.0,7.0,adl>=4 (>=5 if sur),7.0
80.172,male,0.0,CHF,8.0,$11-$25k,6148.0,white,no,0.949999809,0.7999997,no dnr,6.0,83.0,15.8984375,85.0,20.0,36.0,462.5,2.8999023,0.29998779,1.29980469,136.0,7.349609,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
79.96997,male,0.0,CHF,14.0,$11-$25k,17554.0,other,no,0.699999809,0.5,no dnr,11.0,69.0,11.1992188,62.0,20.0,36.5,352.375,2.8999023,0.89990234,1.5,140.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
66.45599,male,0.0,CHF,16.0,under $11k,25668.0,white,no,0.699999809,0.5,no dnr,12.0,85.0,4.79980469,70.0,20.0,36.39844,224.0,3.699707,1.19995117,0.89990234,129.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.116,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,33960.0,white,no,0.199999928,0.1999999,dnr after sadm,4.0,66.0,18.8984375,130.0,30.0,37.69531,81.32812,2.2998047,10.5,0.79992676,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7563477
67.49097,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,172597.0,white,no,0.899999619,0.8999996,no dnr,24.0,100.0,18.296875,102.0,20.0,37.39844,156.0,4.7998047,1.39990234,5.79980469,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7509766
52.09,male,0.0,Cirrhosis,8.0,$11-$25k,13414.0,white,no,0.899999619,0.7999997,no dnr,11.0,89.0,6.39941406,92.0,20.0,37.39844,442.8125,2.199707,10.8984375,1.19995117,133.0,7.429688,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,1.0
66.59296,male,0.0,CHF,8.0,$11-$25k,5872.0,black,no,0.949999809,0.7999997,no dnr,5.0,76.0,6.5,84.0,24.0,36.39844,533.25,3.699707,3.39990234,1.59985352,139.0,7.479492,135.0,23.0,1968.0,1.0,0.0,<2 mo. follow-up,0.0
56.13998,male,0.0,Cirrhosis,12.0,under $11k,6083.0,white,no,0.699999809,0.5,no dnr,5.0,109.0,5.39941406,80.0,20.0,36.59375,224.0,3.0,1.09985352,1.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0625
63.76199,male,0.0,Colon Cancer,12.0,under $11k,7737.0,white,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,104.0,7.79980469,78.0,22.0,36.59375,224.0,2.8999023,0.89990234,1.19995117,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7080078
39.73199,male,0.0,CHF,12.0,under $11k,16616.0,black,no,0.5,0.5,no dnr,8.0,69.0,10.5996094,112.0,22.0,37.19531,224.0,2.8999023,0.89990234,1.39990234,137.0,7.419922,135.0,23.0,1968.0,6.0,4.0,no(M2 and SIP pres),4.0
60.40198,male,0.0,CHF,16.0,>$50k,9381.0,white,no,0.699999809,0.75,no dnr,3.0,80.0,9.09960938,106.0,18.0,37.0,224.0,4.2998047,0.89990234,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
57.771,male,0.0,Colon Cancer,12.0,under $11k,25187.0,other,metastatic,1.0,1.0,no dnr,9.0,111.0,9.29882812,88.0,20.0,38.0,224.0,4.2998047,0.89990234,1.5,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0932617
48.07397,male,0.0,CHF,12.0,under $11k,5570.0,other,no,0.899999619,0.6999998,no dnr,4.0,69.0,8.19921875,88.0,28.0,36.39844,255.0,2.8999023,0.89990234,1.69995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3574219
76.68396,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,229314.0,black,yes,0.699999809,0.5,dnr after sadm,44.0,84.0,24.796875,145.0,16.0,38.69531,150.0,2.8999023,0.29998779,0.79992676,138.0,7.509766,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
78.35699,male,0.0,CHF,12.0,under $11k,4629.0,black,no,0.699999809,0.5,no dnr,4.0,60.0,8.59960938,115.0,20.0,36.0,404.75,2.8999023,0.89990234,1.5,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
85.29999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,20365.0,white,no,0.099999964,0.0009999992,dnr after sadm,1.0,62.0,12.0996094,64.0,36.0,36.89844,142.84375,2.5996094,0.59997559,1.29980469,146.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9472656
62.47498,male,0.0,CHF,11.0,$11-$25k,68367.0,white,no,0.5,0.09999996,no dnr,22.0,55.0,11.2988281,105.0,24.0,36.69531,224.0,3.2998047,2.39990234,1.5,125.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
76.41296,female,0.0,CHF,6.0,under $11k,4386.0,black,no,0.75,0.5,no dnr,4.0,113.0,3.19970703,80.0,20.0,36.29688,224.0,3.0996094,0.79992676,2.19970703,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.3959961
45.11398,male,1.0,Lung Cancer,12.0,under $11k,13100.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,109.0,10.7988281,98.0,18.0,36.39844,224.0,3.199707,0.89990234,0.59997559,130.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7583008
68.12598,female,0.0,Cirrhosis,12.0,under $11k,6992.0,black,no,0.699999809,0.5,no dnr,5.0,80.0,6.39941406,80.0,16.0,37.19531,485.6875,2.5,3.39990234,0.69995117,133.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2592773
82.17694,female,0.0,Lung Cancer,15.0,$25-$50k,15942.0,white,metastatic,0.699999809,0.5,no dnr,10.0,90.0,17.296875,80.0,24.0,37.69531,224.0,4.3994141,1.0,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
41.87,male,0.0,Cirrhosis,12.0,>$50k,68108.0,white,no,0.5,0.5999999,no dnr,15.0,95.0,18.296875,64.0,16.0,36.5,235.0,2.8999023,2.29980469,1.09985352,140.0,7.449219,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
76.20795,female,0.0,Cirrhosis,11.0,under $11k,3644.0,black,no,0.199999928,0.007999994,no dnr,3.0,103.0,4.79980469,90.0,20.0,37.69531,224.0,2.8999023,0.89990234,1.5,124.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
60.04398,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,506141.0,white,no,0.5,0.25,no dnr,11.0,67.0,1.09985352,82.0,26.0,37.39844,228.875,4.0,1.39990234,2.09960938,131.0,7.399414,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
77.13898,male,1.0,ARF/MOSF w/Sepsis,20.0,$11-$25k,159553.0,white,no,0.699999809,0.5,dnr after sadm,8.0,67.0,14.5996094,94.0,24.0,36.19531,156.90625,2.8999023,1.79980469,2.5,137.0,7.5,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
72.96399,female,0.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,42243.0,white,no,0.899999619,0.7999997,no dnr,8.0,56.0,3.89990234,69.0,20.0,38.5,110.0,2.5996094,0.89990234,0.59997559,135.0,7.349609,135.0,23.0,1968.0,4.0,3.0,adl>=4 (>=5 if sur),3.0
59.40598,male,0.0,CHF,12.0,>$50k,19852.0,white,no,0.849999905,0.75,no dnr,9.0,57.0,7.59960938,114.0,28.0,36.5,224.0,4.0,1.09985352,2.79980469,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
72.83795,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,740010.0,white,no,0.699999809,0.5,dnr after sadm,67.0,67.0,11.5996094,95.0,18.0,38.79688,140.0,2.699707,0.89990234,3.5,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.8237305
50.23099,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44480.0,white,no,0.949999809,0.8999996,no dnr,13.0,94.0,11.8984375,97.0,38.0,39.19531,204.0625,2.8999023,0.89990234,1.09985352,140.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4614258
71.56195,female,0.0,Colon Cancer,12.0,$25-$50k,15051.0,white,metastatic,0.949999809,0.5,no dnr,8.0,137.0,15.3984375,80.0,20.0,38.5,224.0,4.3994141,0.89990234,0.69995117,141.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
71.90399,male,0.0,Colon Cancer,10.0,under $11k,24612.0,hispanic,metastatic,0.949999809,0.8573747,no dnr,9.0,106.0,13.8984375,88.0,20.0,36.0,224.0,3.8999023,0.59997559,1.29980469,136.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
44.62997,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40418.0,white,no,0.699999809,0.5,no dnr,6.0,78.0,28.296875,122.0,16.0,38.69531,204.4375,4.1992188,0.89990234,1.0,140.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3632812
51.98398,female,0.0,Colon Cancer,17.0,>$50k,29303.0,white,metastatic,0.949999809,0.8573747,no dnr,12.0,95.0,13.8984375,64.0,18.0,37.5,300.0,4.5996094,1.09985352,0.59997559,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
53.82599,male,0.0,CHF,12.0,$25-$50k,24587.0,hispanic,no,0.849999905,0.6141248,no dnr,16.0,63.0,8.0,96.0,18.0,35.89844,224.0,2.8999023,0.89990234,1.59985352,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6064453
50.431,male,1.0,MOSF w/Malig,12.0,under $11k,70463.0,white,yes,0.699999809,0.5,dnr after sadm,6.0,54.0,12.6992188,136.0,32.0,36.89844,175.0,2.8999023,7.79980469,2.69970703,132.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1044922
31.69099,male,0.0,ARF/MOSF w/Sepsis,14.0,$11-$25k,274531.0,hispanic,no,0.75,0.6999998,no dnr,28.0,140.0,13.3984375,50.0,28.0,38.89844,167.5,3.8999023,27.5,0.89990234,137.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.30896,female,0.0,COPD,12.0,under $11k,84901.0,white,no,0.899999619,0.7999997,no dnr,25.0,99.0,14.5996094,150.0,16.0,37.39844,348.5625,2.8999023,0.89990234,0.69995117,136.0,7.469727,135.0,23.0,1968.0,0.0,1.0,SIP>=30,3.0009766
81.54095,male,0.0,CHF,12.0,$25-$50k,20850.0,white,yes,0.25,0.09999996,no dnr,15.0,84.0,65.0,61.0,20.0,37.19531,359.25,2.2998047,0.89990234,1.79980469,139.0,7.449219,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
66.39795,male,0.0,CHF,16.0,under $11k,17247.0,white,no,0.699999809,0.6999998,no dnr,6.0,59.0,6.09960938,54.0,18.0,36.59375,376.1875,4.1992188,0.89990234,1.5,134.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
50.20099,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,218924.0,white,no,0.099999964,0.0009999992,dnr after sadm,16.0,60.0,3.89990234,145.0,27.0,37.69531,122.5,2.8999023,0.5,3.39990234,134.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5366211
88.29797,male,0.0,CHF,8.0,under $11k,63639.0,white,no,0.699999809,0.5,no dnr,29.0,72.0,11.1992188,80.0,26.0,37.19531,180.0,2.8999023,0.89990234,2.0,131.0,7.479492,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
58.41498,female,0.0,Colon Cancer,14.0,$25-$50k,58940.0,white,metastatic,0.899999619,0.75,no dnr,23.0,91.0,5.09960938,88.0,24.0,37.0,224.0,2.8999023,1.0,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5058594
56.34998,female,0.0,Lung Cancer,12.0,under $11k,26731.0,white,metastatic,0.699999809,0.5,dnr after sadm,7.0,67.0,7.59960938,140.0,36.0,39.0,216.65625,2.8999023,0.89990234,0.79992676,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6875
71.69897,female,0.0,Colon Cancer,19.0,under $11k,5319.0,white,metastatic,0.699999809,0.5,no dnr,5.0,68.0,5.29980469,60.0,20.0,37.0,224.0,3.2998047,0.59997559,0.89990234,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
32.13998,male,1.0,MOSF w/Malig,12.0,under $11k,256835.0,other,yes,0.099999964,0.0009999992,no dnr,27.0,24.0,20.1992188,145.0,30.0,38.69531,222.5,2.8999023,1.0,2.19970703,125.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2148438
48.10999,female,0.0,Cirrhosis,2.0,$11-$25k,56562.0,hispanic,no,0.799999714,0.3999999,no dnr,26.0,77.0,4.79980469,92.0,30.0,36.19531,224.0,2.8999023,17.796875,1.0,131.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
76.383,male,0.0,Colon Cancer,12.0,under $11k,24788.0,other,metastatic,0.949999809,0.75,no dnr,11.0,82.0,5.5,62.0,18.0,37.0,390.4375,4.2998047,0.5,1.0,134.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.262207
57.81,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125797.0,white,no,0.399999857,0.3,dnr after sadm,8.0,113.0,20.5976562,82.0,16.0,37.0,267.5,2.8999023,4.39941406,2.69970703,144.0,7.429688,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
66.76794,female,0.0,Colon Cancer,12.0,under $11k,15358.0,white,metastatic,0.699999809,0.5,no dnr,11.0,79.0,3.29980469,87.0,19.0,36.5,224.0,2.8999023,0.5,1.29980469,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
46.45898,male,0.0,Colon Cancer,16.0,>$50k,21906.0,white,metastatic,0.949999809,0.75,no dnr,7.0,89.0,9.69921875,80.0,20.0,37.5,224.0,4.2998047,0.19998169,1.09985352,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.34796,female,0.0,Colon Cancer,12.0,$11-$25k,77328.0,white,metastatic,0.899999619,0.75,no dnr,20.0,120.0,11.0996094,112.0,28.0,38.79688,224.0,2.699707,0.69995117,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
75.23596,female,0.0,Colon Cancer,12.0,$11-$25k,26189.0,asian,metastatic,0.949999809,0.75,no dnr,12.0,103.0,10.2988281,90.0,20.0,37.0,628.0,4.3994141,0.5,1.29980469,137.0,7.289062,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
74.60394,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,58853.0,white,no,0.699999809,0.5999999,no dnr,14.0,157.0,14.6992188,40.0,16.0,36.0,220.0,2.8999023,0.59997559,1.79980469,136.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6474609
36.45999,female,0.0,Coma,12.0,under $11k,201322.0,white,no,0.699999809,0.5,no dnr,33.0,110.0,16.0,123.0,34.0,39.0,104.0,5.6992188,0.89990234,0.69995117,139.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3637695
63.77298,male,1.0,ARF/MOSF w/Sepsis,16.0,>$50k,89043.0,white,no,0.5,0.15,dnr after sadm,17.0,71.0,11.5996094,96.0,32.0,38.0,128.5625,3.5996094,0.5,0.79992676,127.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4150391
65.70599,male,0.0,Colon Cancer,18.0,$25-$50k,8729.0,hispanic,metastatic,0.699999809,0.5,no dnr,7.0,84.0,10.5,81.0,20.0,37.89844,224.0,2.8999023,5.0,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
20.83199,male,1.0,MOSF w/Malig,12.0,under $11k,392950.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,0.0,5.79980469,0.0,0.0,37.79688,130.0,4.0,10.5,3.59960938,132.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.1416016
52.668,female,1.0,Coma,12.0,under $11k,104602.0,white,no,0.699999809,0.5,no dnr,9.0,88.0,14.8984375,72.0,12.0,36.19531,277.5,2.8999023,0.89990234,0.5,138.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5009766
75.36798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,125256.0,white,no,0.049999982,0.0001249999,no dnr,13.0,63.0,12.8984375,60.0,4.0,37.79688,166.0,2.8999023,1.09985352,8.59960938,132.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9306641
53.86697,male,0.0,CHF,18.0,under $11k,20923.0,white,no,0.699999809,0.5,no dnr,4.0,63.0,6.5,68.0,26.0,36.0,400.0,3.8999023,0.09999084,1.29980469,139.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
44.35898,male,0.0,CHF,12.0,$11-$25k,12042.0,white,no,0.699999809,0.5,no dnr,5.0,69.0,9.5,136.0,20.0,36.39844,261.875,2.8999023,0.5,1.59985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4326172
53.62097,female,0.0,Cirrhosis,12.0,under $11k,279530.0,white,no,0.649999619,0.3999999,no dnr,34.0,76.0,6.5,88.0,18.0,37.19531,224.0,2.199707,1.5,1.09985352,128.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4321289
84.90295,female,0.0,Colon Cancer,15.0,$11-$25k,9291.0,white,metastatic,0.799999714,0.5,no dnr,7.0,86.0,4.79980469,80.0,20.0,36.29688,224.0,3.0996094,0.69995117,1.69995117,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.83899,male,0.0,CHF,12.0,under $11k,10955.0,white,no,0.699999809,0.5,dnr after sadm,2.0,68.0,10.0,61.0,39.0,37.09375,383.625,2.8999023,0.89990234,3.29980469,133.0,7.579102,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.1845703
70.06195,male,0.0,CHF,12.0,under $11k,15687.0,hispanic,no,0.849999905,0.6999998,no dnr,11.0,111.0,7.39941406,80.0,16.0,35.89844,304.75,3.199707,1.39990234,2.69970703,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,SIP>=30,1.0
37.71899,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,268805.0,white,no,0.099999964,0.0009999992,no dnr,9.0,61.0,0.09999084,140.0,45.0,39.09375,238.0,2.8999023,0.79992676,2.79980469,148.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
65.45697,female,1.0,Lung Cancer,13.0,$11-$25k,41397.0,black,metastatic,0.449999809,0.1999999,dnr after sadm,17.0,90.0,18.8984375,68.0,18.0,36.19531,285.6875,3.7998047,0.69995117,1.0,134.0,7.459961,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
29.88399,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,223581.0,white,yes,0.799999714,0.7999997,dnr after sadm,33.0,81.0,10.5996094,118.0,20.0,38.0,95.0,2.5996094,6.0,0.59997559,135.0,7.389648,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
87.521,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,469824.0,white,no,0.699999809,0.5,no dnr,90.0,127.0,15.5,120.0,34.0,37.79688,75.0,2.0996094,0.09999084,1.19995117,134.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3193359
18.146,male,0.0,ARF/MOSF w/Sepsis,12.0,$11-$25k,641888.0,hispanic,no,0.799999714,0.7999997,no dnr,85.0,44.0,2.0,142.0,27.0,37.19531,314.25,1.8999023,0.29998779,10.6992188,134.0,7.349609,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
42.92398,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,277421.0,white,no,0.699999809,0.5,dnr after sadm,9.0,63.0,32.59375,132.0,50.0,39.5,77.32812,2.0996094,0.89990234,1.5,135.0,7.209961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0610352
37.396,female,1.0,Cirrhosis,13.0,$11-$25k,166927.0,black,yes,0.699999809,0.5,dnr after sadm,16.0,73.0,5.89941406,120.0,24.0,37.09375,233.3125,2.8999023,0.89990234,3.19970703,132.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8491211
63.46899,male,0.0,Colon Cancer,12.0,under $11k,29732.0,white,metastatic,0.949999809,0.7999997,no dnr,12.0,124.0,5.39941406,118.0,20.0,37.39844,313.3125,4.6992188,0.79992676,0.79992676,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1762695
53.57999,female,0.0,COPD,12.0,under $11k,5132.0,white,no,0.699999809,0.5,no dnr,5.0,93.0,12.3984375,92.0,12.0,36.59375,256.0,2.8999023,0.29998779,1.09985352,136.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3583984
70.07495,male,0.0,CHF,11.0,$11-$25k,33290.0,black,no,0.699999809,0.5,no dnr,20.0,80.0,10.5996094,90.0,18.0,36.79688,224.0,4.0996094,0.89990234,2.0,132.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
47.633,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,138674.0,asian,no,0.049999982,0.0001249999,dnr after sadm,2.0,25.0,4.5,125.0,10.0,36.0,167.34375,2.8999023,32.3984375,3.59960938,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6940918
51.54797,male,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,170244.0,white,yes,0.25,0.015625,no dnr,37.0,65.0,17.5976562,126.0,29.0,37.89844,165.0,2.8999023,0.89990234,0.59997559,132.0,7.469727,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
90.83899,female,0.0,CHF,12.0,under $11k,14065.0,white,no,0.5,0.25,dnr after sadm,1.0,100.0,10.8984375,82.0,22.0,36.19531,210.0,2.8999023,0.89990234,1.0,145.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8759766
35.625,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,23421.0,black,no,0.699999809,0.5,no dnr,3.0,25.0,19.796875,150.0,28.0,37.19531,309.5,2.8999023,0.89990234,2.5,135.0,7.15918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0986328
63.85999,female,1.0,Coma,12.0,under $11k,47424.0,white,no,0.699999809,0.5,no dnr,9.0,139.0,8.29882812,122.0,10.0,38.69531,350.0,2.8999023,0.89990234,0.69995117,149.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5307617
67.04199,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,100735.0,white,no,0.979999542,0.9499998,no dnr,31.0,129.0,9.3984375,125.0,36.0,38.0,272.5,3.199707,0.89990234,1.0,138.0,7.489258,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
61.16098,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,970982.0,white,no,0.5,0.5,no dnr,106.0,66.0,14.6992188,105.0,20.0,36.5,274.0,3.199707,6.09960938,2.59960938,134.0,7.40918,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.8037109
77.13098,male,0.0,Lung Cancer,12.0,under $11k,29403.0,white,metastatic,0.699999809,0.5,no dnr,5.0,62.0,5.59960938,82.0,12.0,36.39844,276.1875,2.8999023,0.89990234,1.19995117,135.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9814453
19.14,male,0.0,CHF,12.0,$25-$50k,216359.0,white,no,0.699999809,0.5,no dnr,56.0,61.0,8.5,108.0,26.0,36.5,224.0,4.2998047,1.09985352,0.89990234,125.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
64.18097,male,0.0,Colon Cancer,14.0,$11-$25k,26311.0,white,metastatic,0.899999619,0.75,no dnr,11.0,100.0,9.29882812,120.0,18.0,37.5,224.0,4.2998047,1.09985352,0.79992676,133.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
53.30298,female,0.0,Colon Cancer,12.0,under $11k,17823.0,white,metastatic,0.949999809,0.8999996,no dnr,9.0,89.0,10.1992188,120.0,20.0,39.69531,224.0,2.8999023,0.39996338,0.69995117,138.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
55.28799,female,0.0,CHF,13.0,under $11k,19419.0,white,yes,0.799999714,0.1999999,no dnr,9.0,59.0,5.79980469,145.0,20.0,37.0,456.625,2.8999023,0.79992676,0.89990234,133.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.1230469
53.14697,male,0.0,CHF,14.0,under $11k,16552.0,asian,no,0.799999714,0.3999999,no dnr,6.0,75.0,6.69921875,72.0,18.0,36.09375,224.0,4.6992188,2.79980469,1.09985352,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
32.44098,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,1273347.0,white,no,0.299999952,0.3,no dnr,281.0,51.0,16.6992188,96.0,30.0,37.39844,108.5625,2.3999023,1.0,0.69995117,143.0,7.509766,135.0,23.0,1968.0,0.0,7.0,Coma or Intub,7.0
58.95999,female,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,207902.0,white,no,0.799999714,0.75,no dnr,26.0,115.0,6.19921875,132.0,20.0,39.79688,326.625,2.8999023,0.89990234,0.59997559,136.0,7.5,135.0,23.0,1968.0,0.0,0.0,adl>=4 (>=5 if sur),0.0
27.411,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,122322.0,white,no,0.5,0.7999997,no dnr,27.0,78.0,27.5976562,130.0,8.0,38.5,228.0,2.5996094,1.59985352,0.69995117,137.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
77.09497,male,0.0,CHF,16.0,>$50k,23862.0,white,no,0.299999952,0.09999996,no dnr,9.0,93.0,11.5996094,86.0,22.0,36.59375,224.0,2.8999023,0.89990234,3.39990234,137.0,7.419922,135.0,23.0,1968.0,3.0,0.0,<2 mo. follow-up,0.0
63.69299,female,0.0,CHF,11.0,$11-$25k,46112.0,white,no,0.699999809,0.5,dnr after sadm,3.0,52.0,10.6992188,122.0,32.0,39.09375,224.0,2.8999023,0.89990234,0.89990234,134.0,7.419922,135.0,23.0,1968.0,3.0,3.0,SIP>=30,3.0
62.185,female,0.0,Lung Cancer,12.0,under $11k,35575.0,black,metastatic,0.799999714,0.6999998,no dnr,18.0,86.0,7.69921875,60.0,18.0,37.19531,224.0,4.3994141,0.19998169,0.89990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.390625
53.52197,female,0.0,COPD,12.0,$11-$25k,20893.0,white,no,0.899999619,0.6999998,no dnr,9.0,92.0,10.5996094,112.0,36.0,37.5,174.96875,3.2998047,0.29998779,0.69995117,139.0,7.369141,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),4.2832031
23.39999,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,943804.0,hispanic,no,0.899999619,0.8999996,no dnr,96.0,87.0,5.19921875,144.0,45.0,37.29688,335.0,3.0,4.09960938,1.19995117,130.0,7.469727,135.0,23.0,1968.0,0.0,0.0,Coma or Intub,0.0
65.60999,female,0.0,CHF,12.0,under $11k,25467.0,white,no,0.699999809,0.5,no dnr,7.0,94.0,7.39941406,140.0,24.0,35.79688,390.4375,2.8999023,0.89990234,2.69970703,122.0,7.479492,135.0,23.0,1968.0,0.0,2.0,SIP>=30,2.0
70.28094,male,1.0,Cirrhosis,12.0,under $11k,28159.0,white,no,1.0,1.0,no dnr,14.0,106.0,10.3984375,74.0,20.0,37.0,224.0,3.0996094,4.69921875,3.0,129.0,7.419922,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
60.71997,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,63858.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,47.0,14.7988281,80.0,14.0,35.79688,135.0,2.5996094,1.89990234,4.0,138.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6665039
77.00494,female,0.0,CHF,12.0,under $11k,15565.0,white,no,0.5,0.25,no dnr,11.0,99.0,8.59960938,80.0,24.0,36.5,224.0,2.8999023,0.89990234,1.0,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0146484
42.05298,male,0.0,CHF,12.0,$11-$25k,24897.0,hispanic,no,0.799999714,0.5,no dnr,9.0,62.0,10.0996094,120.0,24.0,36.79688,224.0,4.5,1.0,1.29980469,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.75,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,254366.0,asian,no,0.699999809,0.5,dnr after sadm,6.0,63.0,17.5,150.0,32.0,38.69531,89.0,2.8999023,7.09960938,2.29980469,139.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5249023
71.28796,male,1.0,CHF,15.0,under $11k,4854.0,white,no,0.699999809,0.5,dnr after sadm,1.0,63.0,7.29980469,82.0,12.0,36.19531,224.0,2.8999023,0.89990234,1.69995117,127.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
22.66899,female,0.0,CHF,15.0,under $11k,18751.0,hispanic,no,0.599999905,0.1999999,no dnr,9.0,35.0,6.69921875,115.0,40.0,36.39844,175.5,2.8999023,0.89990234,1.29980469,117.0,7.5,135.0,23.0,1968.0,4.0,1.0,adl>=4 (>=5 if sur),3.1831989
59.12399,female,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,43164.0,white,no,0.699999809,0.5,no dnr,9.0,57.0,17.6992188,156.0,14.0,37.5,170.0,3.0996094,1.29980469,1.5,140.0,7.299805,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
63.896,male,0.0,Cirrhosis,12.0,>$50k,227392.0,hispanic,no,0.699999809,0.5,no dnr,55.0,72.0,8.59960938,105.0,18.0,38.39844,338.0625,2.3999023,9.0,1.0,135.0,7.469727,135.0,23.0,1968.0,3.0,5.0,SIP>=30,5.0
87.43097,male,1.0,CHF,12.0,under $11k,89889.0,white,no,0.699999809,0.5,dnr after sadm,14.0,75.0,13.3984375,135.0,8.0,37.79688,138.0,2.8999023,0.89990234,3.19970703,125.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5537109
78.89899,male,0.0,COPD,12.0,under $11k,40247.0,white,no,0.799999714,0.5,no dnr,22.0,94.0,8.79882812,75.0,26.0,36.5,326.0625,2.8999023,0.89990234,0.89990234,139.0,7.329102,135.0,23.0,1968.0,2.0,0.0,<2 mo. follow-up,0.0
83.64099,male,0.0,CHF,10.0,under $11k,25653.0,white,no,0.899999619,0.8999996,no dnr,12.0,63.0,10.6992188,62.0,28.0,39.39844,214.28125,2.8999023,1.0,2.5,131.0,7.439453,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.0
47.737,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,592486.0,black,no,0.699999809,0.5,no dnr,116.0,47.0,13.0996094,164.0,31.0,39.29688,52.0,2.8999023,0.89990234,3.0,130.0,7.139648,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,1.0
78.84998,female,0.0,CHF,8.0,under $11k,9914.0,black,no,0.699999809,0.5,no dnr,9.0,114.0,8.3984375,78.0,20.0,37.79688,328.5625,3.8999023,0.79992676,1.29980469,137.0,7.459961,135.0,23.0,1968.0,4.0,6.0,SIP>=30,6.0
51.18399,male,0.0,CHF,6.0,under $11k,22621.0,black,no,0.799999714,0.5999999,no dnr,10.0,88.0,7.0,80.0,18.0,36.69531,224.0,2.8999023,3.5,1.09985352,126.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
61.45398,male,0.0,Colon Cancer,30.0,>$50k,60175.0,white,metastatic,0.949999809,0.75,no dnr,16.0,102.0,12.8984375,90.0,20.0,37.0,224.0,3.5996094,0.5,1.5,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0556641
55.20297,male,0.0,CHF,15.0,under $11k,3035.0,other,no,0.799999714,0.6999998,no dnr,3.0,93.0,11.1992188,74.0,24.0,36.0,224.0,3.8999023,0.69995117,1.29980469,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
74.06396,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,44728.0,white,no,0.699999809,0.5,no dnr,11.0,115.0,10.0,95.0,12.0,37.5,113.84375,2.8999023,0.89990234,1.09985352,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.402832
90.90796,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,69364.0,white,no,0.199999928,0.1999999,dnr after sadm,13.0,133.0,16.296875,115.0,9.0,38.5,372.5,2.7998047,0.89990234,1.0,137.0,7.399414,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
38.94897,male,1.0,Cirrhosis,9.0,$11-$25k,133918.0,hispanic,no,0.75,0.5,dnr after sadm,23.0,64.0,12.0996094,102.0,18.0,36.39844,224.0,2.0,10.1992188,2.79980469,126.0,7.419922,135.0,23.0,1968.0,5.0,3.0,<2 mo. follow-up,3.0
65.14697,female,0.0,Lung Cancer,12.0,under $11k,5223.0,white,metastatic,0.699999809,0.5,no dnr,4.0,83.0,8.09960938,106.0,22.0,36.39844,224.0,2.8999023,0.89990234,0.69995117,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4189453
51.62799,female,0.0,CHF,13.0,$25-$50k,23146.0,white,no,0.699999809,0.5,no dnr,8.0,65.0,15.8984375,88.0,16.0,36.29688,224.0,4.1992188,1.0,1.09985352,128.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
56.20499,male,0.0,Lung Cancer,12.0,under $11k,42041.0,white,metastatic,0.699999809,0.5,no dnr,20.0,107.0,8.19921875,92.0,20.0,37.19531,304.75,4.1992188,0.29998779,0.89990234,135.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7797852
65.88599,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,19662.0,white,no,0.899999619,0.8999996,no dnr,5.0,61.0,8.3984375,60.0,30.0,37.0,217.125,1.8999023,0.69995117,0.5,139.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.237793
69.19598,male,0.0,CHF,14.0,$11-$25k,24859.0,asian,no,0.699999809,0.5,no dnr,9.0,47.0,13.7988281,70.0,20.0,36.79688,565.0,3.699707,0.69995117,2.39990234,126.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
77.74695,male,0.0,Lung Cancer,12.0,under $11k,16325.0,other,metastatic,0.699999809,0.5,no dnr,6.0,89.0,19.296875,80.0,18.0,36.89844,224.0,2.8999023,0.5,1.29980469,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
80.09595,male,0.0,CHF,12.0,$11-$25k,5293.0,white,no,0.699999809,0.5,no dnr,3.0,93.0,10.5996094,80.0,20.0,36.79688,224.0,2.8999023,0.89990234,0.69995117,131.0,7.419922,135.0,23.0,1968.0,5.0,6.0,SIP>=30,6.0
71.54596,male,0.0,Lung Cancer,20.0,>$50k,23304.0,white,metastatic,0.699999809,0.5,no dnr,7.0,120.0,3.5,89.0,26.0,36.89844,257.125,2.8999023,0.59997559,1.19995117,137.0,7.509766,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
60.61899,male,0.0,CHF,14.0,under $11k,49079.0,white,no,0.949999809,0.8999996,no dnr,17.0,50.0,6.09960938,110.0,20.0,36.79688,224.0,3.699707,0.39996338,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
58.478,male,0.0,CHF,12.0,under $11k,3580.0,white,no,0.699999809,0.5,no dnr,4.0,106.0,9.09960938,88.0,36.0,36.39844,224.0,2.8999023,0.89990234,1.89990234,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6030273
52.67899,male,0.0,CHF,16.0,under $11k,17110.0,asian,no,0.899999619,0.8999996,no dnr,5.0,60.0,3.59960938,150.0,16.0,36.79688,224.0,4.0996094,0.69995117,1.09985352,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.48596,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149983.0,white,no,0.699999809,0.5,no dnr,37.0,62.0,14.0996094,80.0,15.0,38.5,146.0,2.3999023,0.39996338,1.09985352,134.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6967773
50.58197,male,0.0,Cirrhosis,10.0,$25-$50k,9113.0,hispanic,no,0.699999809,0.5,no dnr,7.0,70.0,3.59960938,82.0,20.0,36.79688,385.6875,1.8999023,1.79980469,1.59985352,128.0,7.489258,135.0,23.0,1968.0,4.0,1.0,Coma or Intub,3.1831989
25.487,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,126732.0,white,yes,0.699999809,0.5,dnr after sadm,19.0,123.0,1.69995117,100.0,48.0,38.5,191.8125,3.0996094,9.0,2.29980469,143.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3955078
88.69495,male,1.0,Coma,12.0,>$50k,24242.0,white,no,0.699999809,0.5,dnr after sadm,3.0,102.0,11.5996094,123.0,14.0,38.39844,397.125,3.0996094,0.69995117,5.69921875,135.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
68.01898,male,0.0,MOSF w/Malig,12.0,under $11k,659433.0,white,metastatic,0.699999809,0.5,no dnr,81.0,70.0,12.5996094,115.0,10.0,37.5,218.0,2.5996094,7.69921875,2.79980469,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2172852
81.77698,female,0.0,Cirrhosis,7.0,under $11k,5405.0,black,no,0.699999809,0.7999997,no dnr,7.0,107.0,3.59960938,92.0,26.0,36.79688,224.0,2.199707,0.89990234,0.69995117,138.0,7.419922,135.0,23.0,1968.0,5.0,0.0,SIP>=30,0.0
71.86298,male,0.0,CHF,12.0,under $11k,3869.0,white,no,0.699999809,0.5,no dnr,3.0,87.0,8.09960938,80.0,20.0,36.09375,342.8125,2.8999023,0.89990234,1.5,138.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2963867
72.19696,female,0.0,CHF,12.0,under $11k,9991.0,black,no,0.699999809,0.5,no dnr,8.0,107.0,6.69921875,72.0,18.0,36.79688,224.0,2.8999023,0.89990234,2.29980469,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4404297
53.40997,male,0.0,ARF/MOSF w/Sepsis,14.0,under $11k,102911.0,white,no,0.949999809,0.8999996,no dnr,12.0,113.0,25.5,120.0,25.0,37.29688,260.0,2.5,5.79980469,0.79992676,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5112305
34.35699,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,110596.0,hispanic,no,0.199999928,0.007999994,no dnr,8.0,48.0,6.19921875,120.0,33.0,38.5,150.0,2.3999023,6.0,2.29980469,130.0,7.30957,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
56.66498,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,206651.0,white,no,0.5,0.5,dnr after sadm,10.0,63.0,18.5976562,125.0,30.0,38.5,148.0,2.8999023,16.796875,4.09960938,147.0,7.189453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3227539
53.67798,female,0.0,Cirrhosis,13.0,under $11k,14583.0,white,no,0.5,0.25,no dnr,11.0,113.0,7.5,100.0,24.0,37.0,224.0,2.0,19.8984375,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.32898,male,0.0,Lung Cancer,12.0,$25-$50k,11985.0,asian,metastatic,0.699999809,0.5,no dnr,6.0,93.0,10.5996094,112.0,20.0,37.19531,224.0,2.8999023,0.89990234,0.89990234,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
54.056,male,1.0,Coma,18.0,$25-$50k,46156.0,white,no,0.699999809,0.5,dnr after sadm,8.0,110.0,29.5976562,165.0,34.0,39.19531,223.3125,2.8999023,1.89990234,1.69995117,128.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
70.80396,male,1.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,222230.0,hispanic,no,0.699999809,0.5,dnr after sadm,19.0,83.0,16.8984375,135.0,34.0,39.0,296.25,2.8999023,12.0996094,1.39990234,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2109375
86.57098,female,1.0,Coma,12.0,under $11k,10662.0,white,yes,0.699999809,0.5,dnr after sadm,1.0,97.0,15.0996094,80.0,28.0,36.79688,24.0,2.8999023,0.89990234,1.19995117,133.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.831543
52.44897,male,0.0,Lung Cancer,12.0,under $11k,10469.0,white,metastatic,0.699999809,0.5,no dnr,6.0,84.0,11.5,80.0,20.0,36.19531,224.0,4.5,0.29998779,1.0,136.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
50.97897,male,0.0,COPD,14.0,under $11k,27015.0,white,no,0.979999542,0.9499998,no dnr,9.0,122.0,9.09960938,110.0,32.0,36.5,124.48438,2.8999023,0.89990234,0.79992676,137.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.0
77.75995,male,1.0,CHF,14.0,under $11k,34038.0,white,no,0.699999809,0.5,no dnr,7.0,58.0,4.89941406,60.0,16.0,36.19531,224.0,4.2998047,0.89990234,1.59985352,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.18198,male,1.0,MOSF w/Malig,17.0,>$50k,40620.0,white,yes,0.0,0.0,dnr after sadm,4.0,60.0,4.5,190.0,40.0,39.5,90.0,1.6999512,0.5,1.19995117,130.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
34.17398,female,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,39002.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,67.0,1.59985352,85.0,34.0,33.89844,46.0,2.8999023,1.89990234,0.29998779,128.0,7.399414,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.52295,male,0.0,CHF,12.0,under $11k,5853.0,white,no,0.699999809,0.5,no dnr,5.0,97.0,7.19921875,88.0,20.0,36.79688,319.0,4.0,0.69995117,3.19970703,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6611328
50.53,male,0.0,CHF,13.0,under $11k,18574.0,white,no,0.699999809,0.5,no dnr,6.0,66.0,4.89941406,80.0,24.0,36.69531,224.0,2.8999023,0.89990234,1.39990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0595703
56.82397,female,0.0,COPD,12.0,under $11k,49730.0,black,yes,0.699999809,0.6499996,no dnr,15.0,70.0,22.0,60.0,19.0,37.0,165.6875,2.8999023,0.89990234,1.0,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.105957
45.892,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,330735.0,black,no,0.699999809,0.5,no dnr,76.0,115.0,9.79882812,145.0,32.0,38.69531,510.0,2.0,0.29998779,0.89990234,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6865234
69.71698,female,1.0,Coma,12.0,under $11k,21696.0,white,no,0.099999964,0.0009999992,dnr after sadm,3.0,115.0,14.0,95.0,16.0,36.39844,236.65625,2.8999023,0.39996338,1.79980469,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9838867
65.89996,male,0.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,143419.0,white,no,0.799999714,0.7999997,no dnr,20.0,130.0,6.69921875,110.0,26.0,38.19531,365.0,2.0996094,0.19998169,1.19995117,131.0,7.5,135.0,23.0,1968.0,1.0,1.0,<2 mo. follow-up,1.1668997
38.491,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,111543.0,white,no,0.599999905,0.5999999,no dnr,21.0,123.0,12.8984375,125.0,38.0,39.79688,162.0,2.8999023,3.39990234,0.69995117,134.0,7.259766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4545898
65.53595,male,0.0,MOSF w/Malig,27.0,>$50k,61126.0,black,yes,0.5,0.5,no dnr,14.0,108.0,10.6992188,100.0,12.0,39.29688,220.0,2.2998047,0.89990234,1.79980469,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1010742
59.146,male,0.0,Lung Cancer,11.0,under $11k,17737.0,white,metastatic,0.5,0.09999996,no dnr,10.0,74.0,2.69970703,128.0,24.0,38.89844,224.0,2.8999023,1.19995117,0.89990234,138.0,7.419922,135.0,23.0,1968.0,3.0,3.0,<2 mo. follow-up,3.0
53.922,female,0.0,Colon Cancer,16.0,$25-$50k,46135.0,white,metastatic,0.899999619,0.5,no dnr,24.0,83.0,10.5,100.0,24.0,37.39844,224.0,4.5996094,0.39996338,0.79992676,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.050293
40.63199,male,0.0,CHF,1.0,$11-$25k,29551.0,hispanic,no,0.75,0.5999999,no dnr,13.0,95.0,10.5996094,94.0,26.0,36.0,224.0,2.8999023,0.89990234,1.5,140.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
65.67596,male,0.0,Lung Cancer,12.0,under $11k,57969.0,white,metastatic,0.799999714,0.3,dnr after sadm,12.0,64.0,11.3984375,134.0,32.0,38.79688,309.5,2.5996094,0.89990234,0.79992676,132.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
53.10098,male,1.0,CHF,12.0,under $11k,15394.0,white,no,0.699999809,0.5,no dnr,4.0,43.0,13.2988281,150.0,22.0,36.69531,610.0,3.7998047,1.5,1.29980469,132.0,7.679688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8071289
43.28299,female,1.0,MOSF w/Malig,12.0,under $11k,100051.0,white,yes,0.5,0.3,dnr after sadm,3.0,87.0,0.29998779,140.0,44.0,38.5,259.125,2.699707,3.19970703,1.5,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5332031
35.14297,male,0.0,Lung Cancer,14.0,>$50k,7880.0,white,metastatic,0.699999809,0.5,no dnr,5.0,77.0,8.29882812,80.0,18.0,35.39844,224.0,2.8999023,0.89990234,0.89990234,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
51.49899,female,0.0,Cirrhosis,12.0,under $11k,5765.0,white,yes,0.699999809,0.5,no dnr,4.0,87.0,6.09960938,88.0,20.0,36.59375,366.625,2.2998047,2.0,1.19995117,130.0,7.549805,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
76.44897,male,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,92307.0,white,no,0.5,0.5,no dnr,18.0,108.0,14.7988281,140.0,20.0,39.0,224.0,2.8999023,0.89990234,2.0,144.0,7.419922,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
81.24597,female,1.0,Coma,12.0,under $11k,15473.0,white,no,0.049999982,0.0001249999,dnr before sadm,0.0,58.0,8.5,70.0,30.0,37.5,178.0,2.5,1.5,2.29980469,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.2402344
19.60599,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,413774.0,white,no,0.0,0.0,dnr after sadm,5.0,48.0,6.09960938,131.0,12.0,38.79688,156.25,4.3994141,16.3984375,1.09985352,155.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
63.431,male,0.0,ARF/MOSF w/Sepsis,16.0,$11-$25k,409250.0,white,no,0.699999809,0.5999999,no dnr,61.0,90.0,3.39990234,130.0,20.0,37.09375,230.0,2.7998047,4.69921875,2.09960938,141.0,7.489258,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
52.37198,male,0.0,COPD,12.0,under $11k,6622.0,black,no,1.0,1.0,no dnr,5.0,102.0,15.5,80.0,18.0,37.0,300.0,2.8999023,0.89990234,1.0,140.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
38.883,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,34680.0,hispanic,no,0.599999905,0.5,no dnr,15.0,83.0,7.0,110.0,30.0,38.69531,257.125,3.5996094,0.09999084,0.69995117,133.0,7.449219,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
77.67596,male,1.0,MOSF w/Malig,12.0,under $11k,26620.0,white,metastatic,0.699999809,0.5,dnr after sadm,2.0,38.0,10.0996094,110.0,20.0,38.79688,207.6875,2.8999023,2.79980469,2.09960938,131.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7626953
75.96698,female,0.0,Lung Cancer,12.0,under $11k,12424.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,107.0,25.5,100.0,20.0,36.39844,224.0,3.8999023,0.89990234,1.5,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.38699,female,1.0,MOSF w/Malig,12.0,under $11k,221026.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,112.0,1.39990234,70.0,18.0,36.59375,144.0,4.5996094,7.5,3.89990234,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3369141
47.24698,female,0.0,Lung Cancer,16.0,under $11k,29076.0,asian,metastatic,0.899999619,0.5,no dnr,10.0,47.0,12.7988281,140.0,32.0,38.59375,246.9375,2.5996094,1.29980469,1.29980469,135.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9604492
69.66699,male,1.0,Cirrhosis,12.0,under $11k,122908.0,white,no,0.699999809,0.5,dnr after sadm,13.0,93.0,12.2988281,150.0,14.0,37.0,142.84375,2.3999023,5.39941406,0.89990234,138.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5512695
57.58197,male,0.0,CHF,10.0,under $11k,26110.0,white,no,0.849999905,0.75,no dnr,10.0,65.0,5.0,125.0,26.0,36.89844,400.0,3.8999023,2.79980469,1.29980469,140.0,7.539062,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
50.64798,male,0.0,CHF,12.0,under $11k,23376.0,black,no,0.799999714,0.5,no dnr,10.0,67.0,5.29980469,115.0,30.0,36.79688,419.0,3.3999023,1.39990234,1.19995117,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.07898,male,0.0,Colon Cancer,12.0,>$50k,22300.0,white,metastatic,0.949999809,0.75,no dnr,11.0,103.0,4.29980469,110.0,18.0,36.79688,283.3125,4.2998047,0.29998779,1.09985352,142.0,7.379883,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
67.47998,male,0.0,Colon Cancer,12.0,under $11k,11506.0,white,metastatic,0.989999771,0.75,no dnr,11.0,108.0,6.5,58.0,20.0,38.89844,224.0,4.0996094,0.29998779,1.5,143.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2626953
62.875,male,0.0,Colon Cancer,14.0,>$50k,23575.0,white,metastatic,0.949999809,0.75,no dnr,9.0,96.0,12.5,120.0,24.0,39.0,224.0,4.5996094,0.19998169,0.79992676,137.0,7.419922,135.0,23.0,1968.0,2.0,1.0,no(M2 and SIP pres),1.8389997
74.10797,male,1.0,COPD,12.0,$11-$25k,73695.0,white,no,0.5,0.3999999,dnr after sadm,5.0,63.0,22.0,160.0,12.0,37.0,134.0,2.8999023,0.89990234,0.59997559,140.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
66.73199,male,0.0,Colon Cancer,16.0,$25-$50k,30052.0,white,metastatic,0.699999809,0.5,no dnr,18.0,110.0,9.19921875,90.0,28.0,37.19531,224.0,3.8999023,0.5,0.89990234,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
71.39996,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,163714.0,white,no,0.699999809,0.5,dnr after sadm,32.0,120.0,10.7988281,65.0,22.0,36.59375,86.65625,2.8999023,0.5,1.59985352,143.0,7.469727,135.0,23.0,1968.0,5.0,1.0,<2 mo. follow-up,3.855299
60.85699,female,0.0,Lung Cancer,12.0,under $11k,22052.0,white,metastatic,0.699999809,0.5,no dnr,9.0,98.0,3.79980469,110.0,20.0,37.5,196.0,4.1992188,0.09999084,1.09985352,136.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5507812
47.37598,female,1.0,MOSF w/Malig,12.0,$11-$25k,266998.0,white,yes,0.799999714,0.7999997,dnr after sadm,19.0,78.0,7.59960938,130.0,25.0,39.69531,152.0,2.8999023,1.19995117,4.59960938,145.0,7.379883,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
71.15094,female,1.0,CHF,10.0,$11-$25k,27021.0,black,no,0.699999809,0.5,dnr after sadm,10.0,127.0,6.69921875,110.0,24.0,37.5,455.5,2.8999023,1.0,3.5,140.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
64.24597,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,32157.0,hispanic,no,0.949999809,0.9499998,no dnr,15.0,77.0,33.59375,110.0,22.0,38.0,346.625,2.8999023,1.59985352,3.0,143.0,7.269531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
21.63699,female,0.0,Colon Cancer,16.0,>$50k,17730.0,white,metastatic,0.949999809,0.8999996,no dnr,10.0,88.0,17.0976562,74.0,20.0,36.39844,224.0,2.8999023,4.19921875,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
60.58899,male,1.0,Lung Cancer,12.0,>$50k,17989.0,white,metastatic,0.699999809,0.5,dnr after sadm,6.0,117.0,12.3984375,135.0,26.0,36.5,224.0,2.8999023,0.29998779,1.09985352,133.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
55.20599,female,0.0,COPD,12.0,under $11k,28330.0,black,no,0.599999905,0.3999999,no dnr,13.0,93.0,5.79980469,95.0,26.0,37.29688,223.3125,2.8999023,0.89990234,0.69995117,142.0,7.379883,135.0,23.0,1968.0,6.0,6.0,adl>=4 (>=5 if sur),6.0
66.54596,male,1.0,ARF/MOSF w/Sepsis,15.0,>$50k,348628.0,white,no,0.949999809,0.9499998,dnr after sadm,45.0,67.0,19.6992188,150.0,20.0,39.39844,182.5,3.7998047,1.69995117,1.5,127.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9897461
66.66895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,922581.0,asian,no,0.699999809,0.5,dnr after sadm,162.0,112.0,19.5,150.0,19.0,40.19531,177.5,2.5996094,4.09960938,0.89990234,148.0,7.489258,135.0,23.0,1968.0,0.0,1.0,Coma or Intub,2.265625
73.36597,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,536925.0,white,no,0.699999809,0.5,dnr after sadm,64.0,65.0,21.1992188,140.0,14.0,36.5,164.0,2.0,4.79980469,2.39990234,144.0,7.379883,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1137695
37.59299,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,29615.0,white,no,0.799999714,0.5,no dnr,5.0,103.0,7.29980469,120.0,28.0,36.5,380.0,2.8999023,0.89990234,0.79992676,139.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9033203
61.34399,female,0.0,Colon Cancer,11.0,under $11k,30431.0,hispanic,metastatic,0.899999619,0.6999998,no dnr,9.0,140.0,9.79882812,70.0,26.0,37.5,380.0,3.199707,0.89990234,0.89990234,140.0,7.379883,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
65.92499,male,0.0,Colon Cancer,16.0,>$50k,6228.0,asian,metastatic,0.5,0.1999999,no dnr,7.0,73.0,5.09960938,82.0,16.0,37.79688,224.0,3.7998047,0.39996338,1.0,137.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
47.33197,female,0.0,COPD,12.0,under $11k,35296.0,white,no,0.5,0.3999999,no dnr,8.0,73.0,12.0996094,140.0,36.0,36.19531,185.6875,2.8999023,0.89990234,0.39996338,133.0,7.339844,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.0380859
32.18298,female,0.0,CHF,12.0,under $11k,12924.0,white,no,0.699999809,0.5,no dnr,10.0,82.0,12.1992188,80.0,28.0,36.0,242.84375,2.8999023,0.89990234,1.39990234,134.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8623047
48.04398,male,1.0,ARF/MOSF w/Sepsis,18.0,under $11k,786088.0,white,no,0.399999857,0.1999999,dnr after sadm,47.0,107.0,21.5,150.0,30.0,37.79688,138.0,2.699707,16.8984375,1.39990234,143.0,7.469727,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
71.66296,female,1.0,Coma,12.0,under $11k,21598.0,white,no,0.009999998,9.999994e-07,dnr after sadm,5.0,113.0,10.1992188,110.0,20.0,39.89844,215.53125,2.8999023,0.89990234,0.89990234,127.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2768555
64.45197,male,0.0,CHF,12.0,under $11k,30265.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,45.0,16.8984375,135.0,36.0,37.39844,108.15625,3.0,1.29980469,1.69995117,126.0,7.549805,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
24.515,female,0.0,ARF/MOSF w/Sepsis,10.0,under $11k,83772.0,hispanic,no,0.5,0.5,no dnr,19.0,120.0,5.69921875,110.0,28.0,37.5,69.0,2.8999023,0.89990234,0.89990234,140.0,7.5,135.0,23.0,1968.0,0.0,4.0,no(M2 and SIP pres),4.0
74.034,female,1.0,Colon Cancer,12.0,under $11k,6429.0,white,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,18.3984375,104.0,24.0,36.19531,224.0,2.8999023,3.29980469,0.69995117,127.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3735352
72.03296,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,61750.0,white,no,0.699999809,0.5,dnr after sadm,11.0,117.0,15.3984375,120.0,12.0,37.59375,60.0,3.0,0.29998779,1.69995117,138.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8081055
68.60797,male,0.0,CHF,12.0,under $11k,8303.0,white,no,0.799999714,0.6999998,no dnr,7.0,87.0,10.5996094,80.0,24.0,36.5,332.0,2.8999023,0.89990234,1.79980469,142.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9321289
59.40598,male,0.0,CHF,14.0,$11-$25k,157585.0,asian,no,0.699999809,0.5,no dnr,46.0,78.0,7.19921875,80.0,24.0,37.0,224.0,2.8999023,0.5,1.0,132.0,7.419922,135.0,23.0,1968.0,3.0,1.0,no(M2 and SIP pres),1.0
20.312,male,1.0,ARF/MOSF w/Sepsis,13.0,under $11k,99728.0,white,no,0.019999996,0.02,no dnr,7.0,117.0,6.29980469,160.0,26.0,40.09375,130.0,2.8999023,2.5,3.0,141.0,7.439453,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
80.19397,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,29857.0,white,no,0.049999982,0.0001249999,dnr after sadm,3.0,98.0,11.0996094,90.0,32.0,38.5,355.5,2.8999023,0.89990234,1.19995117,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9487305
42.06699,male,1.0,MOSF w/Malig,18.0,$11-$25k,137943.0,white,yes,0.699999809,0.5,no dnr,4.0,47.0,2.59960938,175.0,36.0,39.29688,244.875,3.0,4.79980469,5.39941406,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2294922
23.81699,male,0.0,MOSF w/Malig,13.0,$25-$50k,245347.0,black,metastatic,0.699999809,0.5,dnr after sadm,3.0,127.0,17.0,140.0,28.0,37.89844,53.32812,2.8999023,0.89990234,1.39990234,135.0,7.429688,135.0,23.0,1968.0,0.0,2.0,adl>=4 (>=5 if sur),2.0
65.97095,male,0.0,CHF,12.0,under $11k,16273.0,white,yes,0.699999809,0.5,no dnr,6.0,52.0,8.8984375,80.0,32.0,36.39844,247.59375,3.5996094,1.79980469,1.19995117,136.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4047852
67.00098,male,0.0,CHF,12.0,under $11k,15242.0,white,no,0.75,0.5999999,no dnr,5.0,42.0,7.79980469,85.0,20.0,36.89844,224.0,3.5996094,0.19998169,1.39990234,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1396484
58.09698,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,150445.0,hispanic,no,0.699999809,0.5,no dnr,21.0,57.0,16.5976562,120.0,10.0,38.29688,192.0,3.199707,0.5,1.09985352,137.0,7.549805,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.3178711
34.99799,female,0.0,Coma,18.0,>$50k,8265.0,white,no,0.5,0.1999999,no dnr,15.0,103.0,10.0996094,115.0,20.0,37.39844,330.0,2.8999023,0.89990234,0.69995117,134.0,7.479492,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
65.96295,male,0.0,ARF/MOSF w/Sepsis,4.0,under $11k,181645.0,hispanic,no,0.699999809,0.5999999,no dnr,55.0,80.0,15.0996094,120.0,30.0,39.0,340.0,3.0996094,0.69995117,0.89990234,142.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.097168
43.85999,female,0.0,Cirrhosis,12.0,$11-$25k,186293.0,hispanic,no,0.5,0.3,no dnr,43.0,46.0,3.5,80.0,20.0,37.19531,300.0,2.3999023,38.3984375,1.89990234,138.0,7.469727,135.0,23.0,1968.0,7.0,3.0,<2 mo. follow-up,3.0
29.769,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,181539.0,asian,no,0.699999809,0.5,no dnr,34.0,110.0,16.0,120.0,30.0,37.69531,397.5,2.0,4.29980469,0.69995117,135.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1264648
52.71997,female,1.0,Cirrhosis,20.0,$11-$25k,45273.0,white,no,0.009999998,9.999994e-07,dnr after sadm,4.0,97.0,9.5,75.0,18.0,36.39844,290.4375,2.8999023,2.0,2.5,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0878906
26.24799,male,1.0,MOSF w/Malig,12.0,under $11k,260829.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,35.0,0.04999542,40.0,52.0,36.69531,206.0,1.6999512,3.79980469,1.89990234,138.0,7.219727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0917969
66.75397,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,306038.0,white,no,0.699999809,0.5,no dnr,46.0,67.0,24.0976562,120.0,22.0,37.0,106.65625,2.8999023,0.89990234,1.29980469,139.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
53.125,male,0.0,Lung Cancer,8.0,$11-$25k,13872.0,white,metastatic,0.699999809,0.5,no dnr,14.0,70.0,9.19921875,72.0,18.0,36.79688,376.1875,2.8999023,0.19998169,1.0,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
70.74097,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,72222.0,white,yes,0.699999809,0.5,no dnr,14.0,77.0,23.0,115.0,28.0,39.0,120.40625,2.7998047,0.09999084,1.19995117,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.4282227
54.67798,male,0.0,CHF,14.0,under $11k,38322.0,white,no,0.699999809,0.5,no dnr,12.0,58.0,10.5996094,65.0,18.0,36.09375,224.0,2.5,1.79980469,1.29980469,145.0,7.5,135.0,23.0,1968.0,3.0,1.0,<2 mo. follow-up,2.5110989
81.45398,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,92518.0,white,no,0.399999857,0.3,no dnr,30.0,60.0,8.3984375,75.0,40.0,38.89844,391.0,3.0,0.89990234,1.09985352,132.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4912109
58.27499,female,0.0,COPD,12.0,under $11k,161257.0,black,no,0.199999928,0.15,no dnr,40.0,77.0,16.5976562,115.0,12.0,37.29688,68.0,3.3999023,0.89990234,0.89990234,144.0,7.299805,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
36.96899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,85027.0,other,no,0.699999809,0.5,dnr after sadm,1.0,111.0,21.6992188,120.0,70.0,39.89844,224.0,4.5,54.296875,5.69921875,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4121094
44.47897,male,0.0,Cirrhosis,16.0,$25-$50k,12696.0,white,no,0.5,0.5,no dnr,8.0,100.0,4.69921875,82.0,18.0,36.79688,224.0,2.2998047,14.1992188,0.79992676,137.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.98096,male,0.0,Colon Cancer,16.0,>$50k,42514.0,white,metastatic,0.899999619,0.75,no dnr,13.0,115.0,4.19921875,70.0,22.0,38.39844,224.0,3.0996094,1.59985352,1.0,142.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
82.245,female,1.0,Coma,12.0,under $11k,73656.0,white,no,0.699999809,0.5,dnr after sadm,3.0,123.0,10.5996094,75.0,9.0,36.69531,295.0,2.8999023,0.89990234,1.19995117,140.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.355957
38.49698,male,0.0,ARF/MOSF w/Sepsis,17.0,>$50k,463001.0,white,no,0.799999714,0.75,no dnr,62.0,73.0,10.0996094,130.0,18.0,38.59375,237.5,3.0996094,13.7988281,1.09985352,145.0,7.529297,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
59.37598,male,0.0,MOSF w/Malig,12.0,under $11k,64372.0,black,yes,0.5,0.3,no dnr,19.0,70.0,0.69995117,120.0,32.0,37.0,396.625,2.0996094,0.69995117,0.89990234,138.0,7.419922,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
58.44998,male,0.0,CHF,20.0,under $11k,30148.0,white,no,0.989999771,0.9499998,no dnr,20.0,85.0,6.19921875,90.0,28.0,37.0,403.3125,2.8999023,0.89990234,1.69995117,133.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
83.30194,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,49455.0,white,no,0.5,0.3,dnr after sadm,9.0,130.0,11.8984375,80.0,10.0,38.5,242.84375,2.8999023,0.89990234,1.0,138.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5644531
43.995,female,0.0,Cirrhosis,12.0,$11-$25k,260514.0,white,no,0.699999809,0.5999999,no dnr,50.0,80.0,20.8984375,130.0,20.0,36.29688,485.0,2.7998047,3.0,1.89990234,136.0,7.459961,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
50.09698,male,0.0,MOSF w/Malig,12.0,under $11k,29840.0,other,yes,0.799999714,0.6999998,no dnr,15.0,97.0,11.0996094,80.0,16.0,37.39844,419.0,2.8999023,0.69995117,1.19995117,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
80.18896,male,1.0,ARF/MOSF w/Sepsis,19.0,>$50k,257589.0,white,no,0.399999857,0.1999999,dnr after sadm,39.0,133.0,10.1992188,120.0,36.0,38.69531,204.4375,2.8999023,0.5,1.09985352,147.0,7.469727,135.0,23.0,1968.0,0.0,2.0,<2 mo. follow-up,2.0
40.20499,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,151181.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,52.0,6.5,150.0,35.0,36.79688,122.0,2.699707,10.5996094,1.19995117,143.0,7.349609,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0107422
57.01797,female,0.0,CHF,12.0,under $11k,12504.0,white,no,0.799999714,0.6999998,no dnr,5.0,93.0,12.1992188,88.0,18.0,37.19531,423.75,4.6992188,0.59997559,0.89990234,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4633789
38.90799,female,0.0,ARF/MOSF w/Sepsis,13.0,under $11k,48336.0,white,no,0.899999619,0.8999996,no dnr,12.0,107.0,18.6992188,120.0,28.0,37.5,280.0,2.8999023,0.89990234,4.29980469,125.0,7.289062,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
75.54297,male,0.0,Colon Cancer,14.0,$25-$50k,18233.0,white,metastatic,0.949999809,0.7999997,no dnr,11.0,93.0,13.8984375,84.0,20.0,36.19531,224.0,2.8999023,1.19995117,1.0,136.0,7.419922,135.0,23.0,1968.0,2.0,0.0,no(M2 and SIP pres),0.0
34.80899,female,1.0,MOSF w/Malig,12.0,under $11k,71315.0,white,metastatic,0.699999809,0.5,dnr after sadm,5.0,62.0,0.69995117,135.0,60.0,38.5,82.0,2.5996094,6.09960938,0.5,141.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0834961
73.72998,male,0.0,Colon Cancer,12.0,under $11k,41836.0,white,metastatic,0.699999809,0.5,no dnr,15.0,127.0,5.29980469,88.0,18.0,36.79688,224.0,4.2998047,1.69995117,1.09985352,141.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1674805
42.543,male,1.0,MOSF w/Malig,12.0,under $11k,217970.0,white,yes,0.699999809,0.5,dnr after sadm,8.0,50.0,1.09985352,140.0,30.0,38.5,396.625,2.8999023,0.89990234,6.69921875,137.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6279297
68.70099,male,0.0,Lung Cancer,12.0,under $11k,8570.0,white,metastatic,0.699999809,0.5,no dnr,4.0,121.0,4.19921875,74.0,8.0,37.79688,224.0,2.8999023,0.89990234,1.0,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2436523
73.56299,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,192983.0,white,yes,0.199999928,0.007999994,dnr after sadm,20.0,133.0,28.5976562,140.0,39.0,38.89844,61.0,2.8999023,0.89990234,0.79992676,132.0,7.399414,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9082031
69.10297,female,0.0,Colon Cancer,12.0,under $11k,39080.0,white,metastatic,0.699999809,0.5,no dnr,12.0,97.0,10.6992188,115.0,28.0,37.29688,224.0,3.0,3.89990234,0.89990234,145.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4438477
67.41095,male,1.0,Coma,12.0,under $11k,19247.0,white,no,0.699999809,0.5,dnr after sadm,4.0,35.0,13.0,140.0,10.0,41.0,171.40625,2.8999023,0.89990234,4.29980469,151.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9233398
79.72095,male,1.0,CHF,18.0,>$50k,23327.0,asian,no,0.699999809,0.5,dnr after sadm,2.0,33.0,8.09960938,100.0,16.0,36.19531,224.0,2.8999023,0.89990234,5.5,129.0,7.419922,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
48.35898,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,60676.0,hispanic,no,0.049999982,0.0001249999,dnr after sadm,3.0,87.0,3.69970703,125.0,17.0,36.59375,90.65625,2.8999023,0.89990234,0.59997559,143.0,7.439453,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.67398,male,1.0,CHF,12.0,>$50k,481475.0,white,no,0.699999809,0.5,dnr after sadm,72.0,77.0,9.29882812,100.0,36.0,36.59375,127.5,2.8999023,0.89990234,2.59960938,125.0,7.529297,135.0,23.0,1968.0,0.0,3.0,adl>=4 (>=5 if sur),3.0
58.31897,female,0.0,Cirrhosis,12.0,under $11k,5877.0,hispanic,no,0.699999809,0.5,no dnr,5.0,87.0,4.89941406,80.0,20.0,37.19531,224.0,2.199707,4.79980469,1.0,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1245117
59.88498,male,0.0,CHF,14.0,$25-$50k,25441.0,white,no,0.699999809,0.5,no dnr,11.0,67.0,9.29882812,110.0,18.0,36.79688,224.0,4.1992188,0.39996338,1.39990234,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
64.02698,male,0.0,CHF,12.0,under $11k,11926.0,white,no,0.699999809,0.5,no dnr,4.0,62.0,5.39941406,70.0,18.0,36.5,252.375,4.5996094,1.19995117,1.09985352,136.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.6655273
34.461,female,1.0,MOSF w/Malig,12.0,under $11k,193371.0,white,yes,0.699999809,0.5,dnr after sadm,3.0,33.0,1.09985352,130.0,35.0,35.89844,80.0,2.5,0.89990234,1.29980469,141.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.9511719
47.33499,female,0.0,Colon Cancer,12.0,under $11k,53037.0,white,metastatic,0.699999809,0.5,no dnr,26.0,93.0,10.0,100.0,20.0,38.59375,224.0,4.0,6.19921875,0.69995117,140.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6083984
47.77798,female,0.0,Cirrhosis,12.0,under $11k,14867.0,other,no,0.699999809,0.5,no dnr,7.0,91.0,5.59960938,76.0,20.0,37.0,224.0,1.8999023,5.29980469,0.69995117,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1303711
49.28998,male,1.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,73143.0,white,no,0.5,0.5,no dnr,6.0,47.0,2.39990234,160.0,40.0,34.0,85.0,2.8999023,0.89990234,3.0,139.0,7.069336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1860352
51.573,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,121630.0,white,metastatic,0.699999809,0.5,dnr after sadm,22.0,98.0,10.0996094,85.0,28.0,37.19531,44.4375,3.3999023,1.89990234,1.29980469,133.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3798828
73.90295,male,0.0,CHF,16.0,under $11k,6676.0,white,no,0.699999809,0.5,no dnr,4.0,100.0,14.8984375,100.0,20.0,36.79688,224.0,2.8999023,0.89990234,1.5,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2524414
71.28497,male,0.0,Lung Cancer,12.0,under $11k,16142.0,white,metastatic,1.0,0.9499998,no dnr,7.0,95.0,16.0,70.0,22.0,37.5,495.1875,2.8999023,0.89990234,1.39990234,137.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5341797
55.29898,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,85170.0,white,no,0.699999809,0.5,no dnr,11.0,83.0,8.09960938,150.0,32.0,38.69531,350.0,2.8999023,0.89990234,0.89990234,130.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.8974609
52.68997,male,0.0,MOSF w/Malig,12.0,under $11k,50315.0,white,metastatic,0.699999809,0.5,no dnr,8.0,125.0,15.5996094,118.0,36.0,37.0,310.0,2.8999023,0.89990234,0.89990234,141.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7290039
81.38794,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,207883.0,white,no,0.699999809,0.5,dnr after sadm,9.0,63.0,17.5,70.0,37.0,39.0,285.0,2.199707,3.19970703,4.19921875,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1708984
49.29999,male,0.0,Cirrhosis,12.0,under $11k,241565.0,white,no,0.099999964,0.0009999992,no dnr,29.0,87.0,5.79980469,110.0,16.0,35.19531,194.28125,2.199707,4.0,3.09960938,148.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9243164
64.69299,male,0.0,Colon Cancer,12.0,$25-$50k,24410.0,white,metastatic,0.899999619,0.75,no dnr,9.0,67.0,9.8984375,110.0,12.0,37.5,215.0,4.5,0.79992676,1.09985352,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
61.67798,male,0.0,Colon Cancer,12.0,>$50k,18565.0,white,metastatic,0.899999619,0.7999997,no dnr,9.0,95.0,11.7988281,88.0,20.0,37.0,224.0,2.8999023,0.59997559,1.29980469,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5693359
64.25195,male,0.0,CHF,6.0,under $11k,7339.0,white,no,0.699999809,0.5,no dnr,4.0,73.0,3.89990234,110.0,24.0,36.39844,256.625,2.8999023,0.89990234,1.5,136.0,7.339844,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.1958008
56.95798,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,80188.0,other,no,0.699999809,0.5,dnr after sadm,7.0,68.0,17.5,125.0,32.0,36.39844,193.875,2.8999023,35.0,9.09960938,146.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5454102
29.71399,male,1.0,MOSF w/Malig,12.0,under $11k,55429.0,other,yes,0.699999809,0.5,dnr after sadm,7.0,120.0,2.69970703,55.0,14.0,36.09375,190.0,2.8999023,0.89990234,1.5,128.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3691406
35.56998,female,0.0,MOSF w/Malig,19.0,>$50k,141926.0,black,yes,0.699999809,0.5,no dnr,33.0,113.0,0.04999542,120.0,28.0,37.59375,419.0,2.5,1.09985352,0.69995117,133.0,7.459961,135.0,23.0,1968.0,5.0,6.0,<2 mo. follow-up,6.0
38.42297,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36468.0,black,no,0.699999809,0.5,no dnr,10.0,114.0,21.0,98.0,20.0,38.0,224.0,2.8999023,0.89990234,10.5,131.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4711914
62.53497,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,188728.0,white,no,0.5,0.3999999,dnr after sadm,1.0,88.0,3.69970703,130.0,24.0,39.5,140.0,2.8999023,0.89990234,1.19995117,148.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7363281
76.49597,male,1.0,Lung Cancer,12.0,under $11k,7422.0,white,metastatic,0.199999928,0.09999996,dnr after sadm,2.0,110.0,13.8984375,72.0,26.0,36.19531,209.0625,2.8999023,0.39996338,2.0,146.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
83.16199,male,1.0,Coma,12.0,under $11k,13767.0,white,no,0.699999809,0.5,dnr after sadm,2.0,93.0,18.0,150.0,32.0,37.89844,593.0,2.8999023,0.89990234,1.19995117,136.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2773438
57.52798,male,0.0,Coma,12.0,under $11k,82244.0,white,no,0.099999964,0.0009999992,no dnr,20.0,60.0,19.796875,75.0,15.0,36.89844,210.0,2.8999023,0.89990234,1.0,137.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3989258
73.66498,male,0.0,Colon Cancer,12.0,under $11k,9640.0,white,metastatic,0.599999905,0.1999999,dnr after sadm,1.0,93.0,3.5,84.0,20.0,36.39844,224.0,2.8999023,0.89990234,1.5,133.0,7.419922,135.0,23.0,1968.0,0.0,3.0,<2 mo. follow-up,3.0
46.51099,male,0.0,Cirrhosis,15.0,$25-$50k,603388.0,black,no,0.5,0.5,no dnr,74.0,67.0,17.5976562,110.0,36.0,39.0,420.0,1.5,31.5976562,5.5,137.0,7.629883,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
78.91895,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,219537.0,white,no,0.699999809,0.5,dnr after sadm,28.0,60.0,27.5976562,100.0,18.0,38.5,282.8125,2.699707,0.89990234,2.59960938,140.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2841797
68.91394,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,30869.0,white,no,0.699999809,0.5,no dnr,11.0,67.0,16.0976562,135.0,32.0,37.19531,222.84375,3.0996094,0.59997559,0.5,135.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.762207
42.29199,female,1.0,MOSF w/Malig,12.0,under $11k,161776.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,42.0,14.2988281,115.0,35.0,38.39844,32.0,2.8999023,1.69995117,3.5,125.0,7.25,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1401367
46.57898,male,0.0,CHF,22.0,under $11k,17254.0,black,no,0.699999809,0.5,no dnr,7.0,72.0,6.29980469,100.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.59985352,136.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
54.03998,male,0.0,CHF,16.0,>$50k,135849.0,white,no,0.699999809,0.5,no dnr,15.0,68.0,5.29980469,110.0,12.0,36.09375,353.3125,3.0996094,1.79980469,1.19995117,129.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
45.10599,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,35204.0,white,no,0.699999809,0.5,no dnr,8.0,92.0,8.0,120.0,36.0,37.09375,142.84375,2.8999023,0.89990234,1.29980469,134.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7602539
87.46295,female,0.0,CHF,12.0,>$50k,12163.0,white,no,0.949999809,0.7999997,no dnr,10.0,93.0,8.3984375,84.0,20.0,36.39844,342.8125,2.8999023,0.89990234,0.79992676,126.0,7.489258,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.7792969
79.24695,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,174898.0,black,no,0.699999809,0.5,dnr after sadm,18.0,73.0,10.5996094,110.0,25.0,37.59375,115.0,2.0996094,0.89990234,1.09985352,135.0,7.5,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
39.73999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,352017.0,other,no,0.699999809,0.5,no dnr,4.0,60.0,20.5976562,130.0,44.0,39.29688,238.0,3.2998047,11.0996094,4.59960938,146.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2241211
78.17395,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,372459.0,asian,no,0.699999809,0.5,dnr after sadm,5.0,45.0,10.5,120.0,28.0,36.89844,317.5,5.7998047,23.1992188,2.29980469,131.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9794922
79.13196,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,36811.0,white,metastatic,0.699999809,0.5,no dnr,13.0,47.0,18.1992188,90.0,22.0,37.19531,100.0,2.8999023,0.69995117,0.89990234,136.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.6357422
70.63898,male,0.0,ARF/MOSF w/Sepsis,18.0,under $11k,104045.0,white,no,0.149999976,0.003374999,no dnr,32.0,80.0,11.2988281,95.0,18.0,37.0,148.3125,4.1992188,0.69995117,5.79980469,139.0,7.229492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
41.26498,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,597427.0,white,no,0.799999714,0.6999998,dnr after sadm,118.0,53.0,8.09960938,129.0,26.0,36.5,92.0,4.0,11.6992188,4.19921875,151.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),3.331543
38.35699,female,0.0,Colon Cancer,12.0,under $11k,5573.0,white,metastatic,0.699999809,0.5,no dnr,5.0,71.0,8.3984375,80.0,16.0,36.79688,224.0,3.0,0.5,0.79992676,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.0043945
59.92099,male,0.0,Lung Cancer,12.0,under $11k,19491.0,black,metastatic,0.699999809,0.5,dnr after sadm,6.0,81.0,20.5976562,72.0,18.0,36.39844,118.35938,3.5996094,0.89990234,1.59985352,130.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5507812
58.11899,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,40421.0,white,no,0.699999809,0.5,dnr after sadm,2.0,15.0,0.89990234,40.0,20.0,33.09375,245.0,2.0996094,1.39990234,2.69970703,127.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.1513672
35.25,female,0.0,MOSF w/Malig,12.0,under $11k,271731.0,white,yes,0.699999809,0.5,no dnr,38.0,60.0,6.79980469,135.0,33.0,39.0,128.875,3.0,0.19998169,5.5,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2861328
66.18994,female,0.0,ARF/MOSF w/Sepsis,15.0,under $11k,53786.0,white,no,0.699999809,0.5,no dnr,12.0,113.0,13.0996094,110.0,20.0,36.0,232.5,2.8999023,0.89990234,1.69995117,143.0,7.429688,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
41.02698,male,1.0,ARF/MOSF w/Sepsis,16.0,under $11k,237244.0,white,no,0.799999714,0.6999998,dnr after sadm,16.0,57.0,4.0,120.0,18.0,35.19531,175.0,2.8999023,9.59960938,2.0,141.0,7.429688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1860352
54.93198,male,0.0,Cirrhosis,12.0,under $11k,25024.0,white,no,0.099999964,0.0009999992,no dnr,49.0,43.0,8.5,120.0,14.0,38.89844,763.25,2.8999023,0.89990234,3.79980469,145.0,7.55957,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.9755859
78.58997,male,1.0,Colon Cancer,12.0,under $11k,5871.0,black,metastatic,0.699999809,0.5,dnr after sadm,1.0,73.0,8.69921875,90.0,20.0,35.59375,224.0,2.8999023,0.89990234,1.0,144.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1899414
82.21497,male,0.0,ARF/MOSF w/Sepsis,10.0,$11-$25k,135785.0,white,no,0.5,0.5,no dnr,37.0,63.0,9.3984375,50.0,14.0,36.59375,148.0,3.0996094,0.89990234,1.19995117,143.0,7.509766,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),1.0
40.34198,male,1.0,MOSF w/Malig,16.0,>$50k,370093.0,white,yes,0.699999809,0.5,dnr after sadm,37.0,57.0,1.29980469,140.0,16.0,38.69531,184.0,2.8999023,1.19995117,5.79980469,139.0,7.40918,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
60.84097,male,1.0,CHF,16.0,under $11k,173498.0,white,no,0.75,0.75,no dnr,23.0,63.0,10.6992188,110.0,18.0,37.09375,120.0,2.8999023,1.09985352,1.59985352,136.0,7.489258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.7094727
67.82996,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,242746.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,58.0,9.59960938,85.0,16.0,39.79688,65.0,2.8999023,0.89990234,5.69921875,145.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4858398
65.41296,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,86956.0,black,no,0.199999928,0.1999999,dnr after sadm,5.0,57.0,19.6992188,110.0,90.0,34.5,87.5,2.8999023,4.09960938,2.5,133.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5546875
74.297,male,0.0,CHF,18.0,>$50k,19565.0,white,no,0.5,0.25,no dnr,7.0,62.0,6.5,80.0,18.0,37.0,41.0,2.8999023,0.89990234,2.09960938,134.0,7.169922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
61.78799,female,0.0,Lung Cancer,12.0,under $11k,4226.0,black,metastatic,0.699999809,0.5,no dnr,3.0,93.0,8.09960938,106.0,24.0,37.0,224.0,2.8999023,0.29998779,1.59985352,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.5039062
45.43198,male,1.0,MOSF w/Malig,16.0,$11-$25k,110902.0,hispanic,yes,0.699999809,0.5,dnr after sadm,7.0,63.0,11.7988281,120.0,32.0,37.69531,92.21875,2.2998047,0.89990234,1.69995117,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4604492
62.45297,male,0.0,CHF,16.0,>$50k,269517.0,white,no,0.899999619,0.7999997,no dnr,43.0,63.0,7.89941406,100.0,20.0,36.59375,224.0,2.8999023,0.89990234,1.39990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
70.28094,male,0.0,Colon Cancer,12.0,under $11k,25535.0,white,metastatic,0.699999809,0.5,no dnr,12.0,87.0,20.5976562,76.0,20.0,36.59375,224.0,4.0996094,0.79992676,1.29980469,137.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.3105469
52.28497,female,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,303548.0,white,no,0.699999809,0.6999998,no dnr,29.0,58.0,18.3984375,170.0,36.0,38.29688,173.3125,3.7998047,16.296875,1.5,141.0,7.479492,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
57.76599,male,0.0,CHF,12.0,under $11k,30477.0,black,no,1.0,0.7999997,no dnr,16.0,80.0,11.3984375,120.0,28.0,36.0,490.4375,2.8999023,3.5,1.29980469,136.0,7.55957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3032227
54.74298,male,1.0,MOSF w/Malig,12.0,under $11k,79089.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,72.0,0.04999542,110.0,32.0,37.89844,91.65625,2.0,0.89990234,0.59997559,128.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3017578
54.78198,male,0.0,Lung Cancer,12.0,under $11k,7383.0,black,metastatic,0.699999809,0.5,no dnr,7.0,88.0,5.89941406,114.0,22.0,37.39844,224.0,2.8999023,0.89990234,1.19995117,139.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,0.4947999
46.69998,female,1.0,MOSF w/Malig,12.0,under $11k,105684.0,other,yes,0.699999809,0.5,dnr after sadm,2.0,28.0,0.09999084,135.0,35.0,36.09375,51.0,2.8999023,0.89990234,1.5,132.0,7.319336,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.8427734
36.59097,male,1.0,MOSF w/Malig,12.0,under $11k,80565.0,white,yes,0.699999809,0.5,dnr after sadm,2.0,58.0,0.5,140.0,40.0,38.89844,95.375,3.0,1.69995117,2.29980469,128.0,7.279297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6972656
83.39496,male,0.0,CHF,13.0,$11-$25k,3968.0,black,no,0.699999809,0.5,no dnr,5.0,77.0,5.69921875,80.0,22.0,37.19531,224.0,4.0996094,0.69995117,1.5,141.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
41.29797,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,182264.0,black,no,0.799999714,0.75,dnr after sadm,18.0,52.0,25.6992188,140.0,10.0,39.0,282.8125,2.5996094,0.39996338,4.69921875,128.0,7.40918,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
90.13794,male,0.0,MOSF w/Malig,24.0,under $11k,124700.0,white,metastatic,0.0,0.0,dnr before sadm,-5.0,63.0,25.1992188,65.0,28.0,36.5,172.5,2.0,2.89990234,1.79980469,138.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,5.7294922
20.09599,female,0.0,CHF,12.0,$11-$25k,51152.0,black,no,1.0,0.75,no dnr,18.0,63.0,16.5,125.0,32.0,39.0,224.0,2.8999023,0.89990234,1.39990234,130.0,7.419922,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
38.92999,male,0.0,Cirrhosis,14.0,$25-$50k,4117.0,white,no,0.699999809,0.5,no dnr,4.0,96.0,6.89941406,92.0,22.0,38.39844,224.0,2.5996094,8.29882812,0.79992676,129.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
39.81897,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,79944.0,white,no,0.699999809,0.5,dnr after sadm,3.0,23.0,38.09375,135.0,48.0,36.39844,130.0,4.3994141,5.69921875,3.79980469,138.0,7.199219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0444336
53.09497,female,1.0,Cirrhosis,12.0,under $11k,47800.0,white,no,0.699999809,0.5,dnr after sadm,1.0,65.0,22.1992188,195.0,22.0,40.0,150.0,2.8999023,34.5,2.29980469,137.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5976562
53.38498,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,81459.0,white,no,0.699999809,0.5,no dnr,13.0,73.0,5.19921875,120.0,12.0,38.39844,190.0,3.8999023,0.29998779,7.39941406,128.0,7.359375,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7265625
79.81396,male,0.0,ARF/MOSF w/Sepsis,13.0,$25-$50k,98268.0,white,no,0.5,0.5,dnr after sadm,7.0,102.0,15.8984375,135.0,12.0,38.5,122.0,2.8999023,2.79980469,2.69970703,144.0,7.30957,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.371582
68.45996,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,26493.0,black,metastatic,0.099999964,0.0009999992,dnr after sadm,1.0,100.0,7.29980469,60.0,22.0,37.79688,222.0,2.8999023,0.79992676,0.69995117,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),3.9082031
52.52597,female,0.0,CHF,16.0,$11-$25k,20605.0,black,no,0.5,0.3,no dnr,8.0,63.0,6.0,65.0,20.0,36.39844,400.0,4.0,0.39996338,2.69970703,136.0,7.339844,135.0,23.0,1968.0,6.0,3.0,adl>=4 (>=5 if sur),3.0
62.50198,male,0.0,CHF,4.0,$11-$25k,8761.0,hispanic,no,0.899999619,0.7999997,no dnr,4.0,70.0,9.29882812,60.0,20.0,36.0,352.375,2.8999023,0.29998779,1.5,138.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5043945
57.02899,male,0.0,Cirrhosis,17.0,$11-$25k,145874.0,white,yes,0.5,0.0,dnr after sadm,17.0,67.0,5.09960938,130.0,25.0,37.0,212.5,2.5,8.3984375,1.09985352,136.0,7.55957,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.448,male,0.0,CHF,3.0,under $11k,13444.0,black,no,0.949999809,0.7999997,no dnr,8.0,117.0,7.0,82.0,28.0,36.59375,428.5625,3.8999023,1.09985352,1.19995117,139.0,7.469727,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
87.76697,female,0.0,COPD,16.0,under $11k,109552.0,white,no,0.5,0.3999999,dnr after sadm,1.0,55.0,23.796875,165.0,36.0,37.79688,273.3125,3.0,0.89990234,0.5,143.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4589844
65.71399,male,1.0,Coma,12.0,under $11k,45707.0,white,no,0.0,0.0,dnr after sadm,5.0,43.0,14.8984375,80.0,26.0,38.89844,174.0,2.8999023,9.8984375,7.69921875,137.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.753418
46.97098,female,0.0,COPD,9.0,under $11k,5975.0,hispanic,no,0.699999809,0.5,no dnr,4.0,112.0,8.19921875,72.0,20.0,37.59375,238.09375,2.8999023,0.89990234,0.79992676,139.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
62.10797,male,0.0,CHF,7.0,under $11k,22091.0,white,no,0.5,0.3,no dnr,11.0,95.0,5.5,75.0,22.0,36.0,224.0,3.8999023,0.89990234,1.29980469,138.0,7.419922,135.0,23.0,1968.0,2.0,5.0,SIP>=30,5.0
81.99896,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,117689.0,white,no,0.75,0.5,dnr after sadm,13.0,65.0,31.1992188,50.0,26.0,36.79688,331.375,3.7998047,1.09985352,1.89990234,133.0,7.519531,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9467773
62.53,female,0.0,Colon Cancer,12.0,under $11k,16862.0,white,metastatic,0.849999905,0.8999996,no dnr,16.0,97.0,5.09960938,96.0,20.0,37.39844,342.8125,3.7998047,0.79992676,0.79992676,134.0,7.489258,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
54.52197,female,0.0,CHF,13.0,>$50k,414803.0,white,no,0.799999714,0.5,no dnr,145.0,37.0,7.5,90.0,24.0,36.29688,122.5,3.3999023,1.59985352,1.39990234,135.0,7.469727,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),0.4947999
49.87,male,1.0,MOSF w/Malig,12.0,under $11k,59913.0,white,yes,0.699999809,0.5,dnr after sadm,4.0,57.0,0.09999084,165.0,28.0,41.19531,85.0,2.5,2.09960938,1.69995117,133.0,7.30957,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2265625
61.69199,female,0.0,Colon Cancer,12.0,$11-$25k,75618.0,white,metastatic,0.849999905,0.6999998,no dnr,25.0,103.0,10.3984375,106.0,24.0,38.19531,224.0,3.7998047,0.29998779,2.39990234,141.0,7.419922,135.0,23.0,1968.0,6.0,1.0,no(M2 and SIP pres),4.5273972
39.14899,female,0.0,CHF,12.0,$25-$50k,147711.0,black,no,0.699999809,0.5999999,no dnr,37.0,58.0,6.19921875,105.0,34.0,36.69531,224.0,2.8999023,0.79992676,0.89990234,130.0,7.419922,135.0,23.0,1968.0,5.0,4.0,<2 mo. follow-up,4.0
50.45599,female,1.0,MOSF w/Malig,12.0,under $11k,202111.0,white,yes,0.699999809,0.5,dnr after sadm,5.0,63.0,0.89990234,115.0,16.0,38.19531,89.21875,2.7998047,4.19921875,2.39990234,143.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5595703
50.57599,female,0.0,Cirrhosis,10.0,under $11k,303934.0,white,no,0.799999714,0.7999997,no dnr,46.0,55.0,5.29980469,75.0,12.0,36.19531,443.3125,2.199707,44.3984375,5.09960938,147.0,7.229492,135.0,23.0,1968.0,0.0,2.0,no(M2 and SIP pres),2.0
68.80798,female,0.0,CHF,14.0,under $11k,7354.0,black,no,0.949999809,0.8499999,no dnr,4.0,94.0,5.39941406,84.0,20.0,36.39844,576.0,2.8999023,0.89990234,1.69995117,128.0,7.459961,135.0,23.0,1968.0,4.0,1.0,SIP>=30,3.1831989
46.07797,male,0.0,Cirrhosis,18.0,>$50k,353422.0,white,metastatic,0.699999809,0.5,no dnr,41.0,63.0,3.59960938,170.0,10.0,35.29688,160.0,3.5996094,51.296875,5.0,147.0,7.589844,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
79.16498,female,0.0,CHF,12.0,under $11k,3974.0,white,no,0.899999619,0.7999997,no dnr,3.0,139.0,6.19921875,76.0,24.0,36.39844,466.625,2.8999023,0.89990234,1.0,141.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.2495117
81.758,female,0.0,CHF,8.0,under $11k,22800.0,white,no,0.599999905,0.216,no dnr,15.0,110.0,11.1992188,80.0,24.0,36.39844,285.6875,2.8999023,0.29998779,1.59985352,128.0,7.519531,135.0,23.0,1968.0,0.0,6.0,<2 mo. follow-up,6.0
76.98798,female,0.0,COPD,16.0,under $11k,113045.0,white,no,0.5,0.3,dnr after sadm,7.0,48.0,12.0996094,170.0,28.0,36.5,155.0,2.8999023,0.89990234,0.59997559,134.0,7.40918,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
81.66498,female,1.0,ARF/MOSF w/Sepsis,17.0,$11-$25k,31827.0,white,no,0.699999809,0.5999999,dnr after sadm,2.0,97.0,22.0976562,100.0,24.0,38.39844,225.6875,2.8999023,0.89990234,1.0,135.0,7.449219,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.6464844
54.26999,male,0.0,ARF/MOSF w/Sepsis,16.0,under $11k,44608.0,white,no,0.699999809,0.5,no dnr,13.0,107.0,7.09960938,125.0,28.0,36.0,120.40625,2.8999023,1.19995117,2.29980469,138.0,7.5,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
22.825,male,1.0,MOSF w/Malig,12.0,under $11k,254601.0,white,metastatic,0.699999809,0.5,dnr after sadm,10.0,43.0,2.89990234,145.0,28.0,38.69531,146.0,2.8999023,6.5,4.29980469,139.0,7.359375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9663086
58.43698,female,0.0,Colon Cancer,20.0,>$50k,14670.0,white,metastatic,0.75,0.25,dnr after sadm,2.0,65.0,7.19921875,72.0,12.0,37.0,224.0,3.7998047,0.69995117,0.69995117,135.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
58.28598,male,0.0,Colon Cancer,14.0,>$50k,24073.0,white,metastatic,0.949999809,0.7999997,no dnr,10.0,81.0,11.7988281,72.0,22.0,38.89844,224.0,4.3994141,0.59997559,1.0,139.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
84.29297,female,0.0,CHF,12.0,under $11k,5110.0,white,no,0.899999619,0.7999997,no dnr,3.0,103.0,9.3984375,130.0,20.0,36.0,423.75,2.8999023,0.89990234,1.29980469,137.0,7.609375,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.0571289
47.01999,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,56169.0,white,no,0.5,0.3999999,dnr after sadm,9.0,28.0,10.0,110.0,26.0,36.29688,148.3125,2.8999023,0.89990234,12.0,149.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.171875
42.28897,female,0.0,Cirrhosis,15.0,$11-$25k,6057.0,white,no,0.699999809,0.6999998,no dnr,6.0,70.0,2.59960938,72.0,20.0,37.0,224.0,2.7998047,11.8984375,0.89990234,133.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
86.37097,male,0.0,CHF,12.0,under $11k,14836.0,white,no,0.75,0.5,no dnr,14.0,107.0,4.29980469,80.0,20.0,36.79688,224.0,3.5996094,0.69995117,2.5,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.03125
72.23499,male,0.0,ARF/MOSF w/Sepsis,16.0,>$50k,23972.0,white,no,0.5,0.1999999,dnr after sadm,1.0,95.0,6.09960938,98.0,26.0,37.79688,83.32812,3.0,1.39990234,1.89990234,157.0,7.439453,135.0,23.0,1968.0,0.0,6.0,adl>=4 (>=5 if sur),6.0
85.35199,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,239683.0,white,no,0.049999982,0.0001249999,dnr before sadm,-1.0,33.0,14.0,120.0,35.0,35.89844,170.0,3.7998047,35.6953125,2.59960938,137.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,1.0
49.13898,female,0.0,Lung Cancer,12.0,under $11k,17775.0,black,metastatic,0.199999928,0.04999998,dnr after sadm,2.0,55.0,9.09960938,122.0,28.0,38.29688,224.0,2.8999023,0.89990234,0.69995117,129.0,7.419922,135.0,23.0,1968.0,3.0,5.0,adl>=4 (>=5 if sur),5.0
79.04395,female,1.0,COPD,12.0,under $11k,36520.0,white,yes,0.599999905,0.3999999,dnr after sadm,2.0,120.0,9.29882812,110.0,26.0,36.39844,110.0,3.699707,0.89990234,0.89990234,139.0,7.179688,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,4.4482422
41.61798,male,1.0,MOSF w/Malig,12.0,under $11k,161755.0,white,yes,0.199999928,1.0,dnr after sadm,9.0,127.0,3.19970703,200.0,38.0,36.39844,179.0,2.8999023,2.5,1.19995117,149.0,7.369141,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9682617
25.49199,female,1.0,MOSF w/Malig,12.0,under $11k,359124.0,white,yes,0.199999928,0.1999999,dnr after sadm,3.0,103.0,2.79980469,145.0,46.0,39.0,109.32812,2.8999023,3.09960938,1.09985352,125.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.6630859
50.754,male,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,448431.0,white,no,0.25,0.25,dnr after sadm,13.0,42.0,10.6992188,118.0,12.0,38.89844,270.0,3.5996094,13.6992188,1.69995117,131.0,7.509766,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.8657227
53.09198,female,0.0,Cirrhosis,12.0,>$50k,13434.0,white,no,0.899999619,0.8999996,no dnr,7.0,66.0,13.1992188,102.0,20.0,36.59375,224.0,2.3999023,5.29980469,1.19995117,124.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
75.80798,male,0.0,Lung Cancer,3.0,>$50k,73798.0,white,metastatic,0.399999857,0.04999998,dnr after sadm,12.0,137.0,29.1992188,160.0,56.0,38.0,146.0,2.7998047,0.89990234,1.09985352,143.0,7.469727,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
75.99695,male,1.0,ARF/MOSF w/Sepsis,13.0,$11-$25k,99364.0,white,no,0.699999809,0.5,dnr after sadm,6.0,52.0,23.296875,150.0,44.0,37.0,170.0,2.8999023,3.89990234,4.5,134.0,7.389648,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
54.491,male,0.0,Cirrhosis,12.0,under $11k,9974.0,white,no,1.0,1.0,no dnr,6.0,95.0,6.89941406,78.0,18.0,36.39844,224.0,2.3999023,5.59960938,0.89990234,125.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3310547
27.51799,female,1.0,MOSF w/Malig,12.0,under $11k,132130.0,hispanic,yes,0.5,0.5,dnr after sadm,5.0,76.0,2.79980469,200.0,56.0,38.39844,277.0,2.8999023,1.39990234,2.69970703,136.0,7.289062,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
59.62198,male,0.0,Lung Cancer,12.0,>$50k,11765.0,white,metastatic,1.0,0.5,no dnr,4.0,96.0,11.6992188,104.0,20.0,36.19531,224.0,2.8999023,0.89990234,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
78.12695,female,1.0,ARF/MOSF w/Sepsis,11.0,$11-$25k,107073.0,white,no,0.0,0.0,no dnr,23.0,60.0,24.0976562,70.0,44.0,38.89844,96.65625,2.0,0.89990234,1.09985352,141.0,7.429688,135.0,23.0,1968.0,0.0,7.0,<2 mo. follow-up,7.0
30.023,male,0.0,ARF/MOSF w/Sepsis,15.0,$25-$50k,108131.0,white,no,0.699999809,0.5,no dnr,17.0,97.0,4.89941406,110.0,12.0,38.59375,267.5,3.0996094,5.79980469,1.09985352,141.0,7.439453,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.0869141
52.70099,female,0.0,Lung Cancer,14.0,$25-$50k,6521.0,white,metastatic,0.699999809,0.15,no dnr,4.0,80.0,9.19921875,64.0,20.0,36.39844,224.0,4.2998047,0.39996338,1.0,140.0,7.419922,135.0,23.0,1968.0,1.0,1.0,no(M2 and SIP pres),1.1668997
52.767,male,1.0,ARF/MOSF w/Sepsis,10.0,under $11k,45767.0,black,no,0.699999809,0.5,no dnr,11.0,77.0,17.0976562,115.0,24.0,38.19531,208.5625,3.3999023,4.0,5.39941406,145.0,7.449219,135.0,23.0,1968.0,0.0,5.0,<2 mo. follow-up,5.0
50.38199,female,0.0,CHF,11.0,under $11k,25748.0,black,no,0.75,0.5999999,no dnr,14.0,60.0,10.5996094,50.0,20.0,36.09375,224.0,2.8999023,0.89990234,0.79992676,138.0,7.419922,135.0,23.0,1968.0,0.0,5.0,adl>=4 (>=5 if sur),5.0
37.336,female,1.0,MOSF w/Malig,12.0,under $11k,168270.0,other,yes,0.799999714,0.7999997,dnr after sadm,3.0,57.0,1.89990234,140.0,14.0,38.5,231.65625,3.2998047,7.5,5.69921875,145.0,7.299805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4541016
65.57697,male,0.0,CHF,16.0,under $11k,42780.0,white,no,0.699999809,0.5,no dnr,10.0,52.0,3.79980469,70.0,30.0,38.29688,251.40625,2.8999023,0.89990234,1.5,142.0,7.529297,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
42.29398,male,1.0,Cirrhosis,12.0,under $11k,49389.0,white,no,0.049999982,0.0001249999,dnr after sadm,5.0,67.0,23.5976562,130.0,32.0,36.5,167.5,3.199707,8.0,2.59960938,134.0,7.529297,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.9550781
55.31799,female,0.0,Cirrhosis,12.0,$11-$25k,16717.0,white,no,0.5,0.3,no dnr,12.0,120.0,7.5,80.0,18.0,37.59375,224.0,2.5,3.69970703,0.59997559,121.0,7.419922,135.0,23.0,1968.0,2.0,1.0,<2 mo. follow-up,1.8389997
51.89899,female,1.0,MOSF w/Malig,12.0,under $11k,85777.0,white,metastatic,0.699999809,0.5,dnr before sadm,-9.0,40.0,3.79980469,120.0,34.0,38.19531,224.0,2.8999023,0.89990234,1.19995117,138.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.7719727
48.98599,male,1.0,Cirrhosis,12.0,under $11k,131400.0,white,no,0.699999809,0.5,dnr after sadm,10.0,60.0,16.3984375,115.0,36.0,38.0,132.0,2.3999023,4.19921875,1.0,138.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5107422
76.33398,male,0.0,CHF,7.0,under $11k,24988.0,white,no,0.699999809,0.5,no dnr,11.0,60.0,5.79980469,72.0,20.0,36.19531,224.0,4.0,2.09960938,1.5,144.0,7.419922,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
24.493,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,149776.0,white,no,0.979999542,0.9799995,no dnr,37.0,108.0,29.796875,140.0,10.0,38.69531,394.25,2.2998047,7.59960938,0.79992676,132.0,7.449219,135.0,23.0,1968.0,0.0,0.0,SIP>=30,0.0
70.46698,female,0.0,ARF/MOSF w/Sepsis,16.0,$25-$50k,57539.0,other,no,0.799999714,0.6999998,no dnr,14.0,135.0,5.09960938,120.0,26.0,37.69531,195.90625,2.8999023,0.89990234,2.29980469,128.0,7.439453,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.690918
58.31897,male,0.0,MOSF w/Malig,23.0,under $11k,542326.0,white,yes,0.399999857,0.09999996,dnr before sadm,-1.0,112.0,4.29980469,205.0,15.0,37.69531,52.0,3.3999023,1.89990234,0.89990234,137.0,7.279297,135.0,23.0,1968.0,0.0,1.0,adl>=4 (>=5 if sur),2.6416016
80.25494,female,1.0,Coma,12.0,under $11k,14297.0,white,no,0.099999964,0.0009999992,dnr after sadm,4.0,127.0,13.5996094,135.0,32.0,38.89844,357.125,2.8999023,0.89990234,0.59997559,138.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.5532227
67.58398,male,0.0,Lung Cancer,12.0,$11-$25k,10819.0,black,metastatic,0.599999905,0.3,no dnr,4.0,97.0,12.0,80.0,20.0,35.79688,224.0,2.8999023,0.89990234,1.19995117,135.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),2.7944336
40.96399,male,1.0,Cirrhosis,16.0,$11-$25k,93417.0,hispanic,no,0.699999809,0.5,dnr after sadm,7.0,70.0,2.29980469,95.0,14.0,36.69531,271.375,3.5996094,38.3984375,4.69921875,136.0,7.389648,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.1333008
26.683,female,0.0,ARF/MOSF w/Sepsis,11.0,under $11k,109747.0,other,no,0.699999809,0.5999999,no dnr,19.0,118.0,24.0976562,120.0,10.0,38.0,58.32812,2.3999023,12.5996094,1.39990234,136.0,7.449219,135.0,23.0,1968.0,0.0,0.0,<2 mo. follow-up,0.0
61.85397,female,1.0,MOSF w/Malig,11.0,under $11k,173968.0,white,yes,0.5,0.3999999,dnr after sadm,20.0,113.0,0.04999542,180.0,28.0,39.69531,352.375,2.0996094,2.29980469,1.79980469,134.0,7.549805,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4663086
77.53595,male,1.0,Coma,12.0,under $11k,20078.0,white,no,0.699999809,0.5,dnr after sadm,2.0,40.0,10.3984375,55.0,10.0,35.59375,64.0,3.8999023,1.29980469,2.29980469,138.0,7.239258,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.9956055
70.03998,female,1.0,ARF/MOSF w/Sepsis,12.0,under $11k,444556.0,white,yes,0.699999809,0.5,no dnr,35.0,93.0,10.5996094,105.0,32.0,39.0,288.0,4.0996094,3.59960938,1.09985352,132.0,7.269531,135.0,23.0,1968.0,0.0,4.0,<2 mo. follow-up,4.0
66.00098,male,0.0,CHF,12.0,$25-$50k,31463.0,white,no,0.599999905,0.5,no dnr,7.0,57.0,8.69921875,115.0,22.0,36.5,224.0,4.7998047,0.39996338,1.59985352,135.0,7.419922,135.0,23.0,1968.0,1.0,0.0,no(M2 and SIP pres),0.0
59.995,female,0.0,COPD,8.0,under $11k,41479.0,hispanic,yes,0.699999809,0.5999999,no dnr,14.0,77.0,4.19921875,95.0,40.0,36.19531,266.625,2.8999023,0.09999084,0.89990234,133.0,7.319336,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.0
49.91599,male,1.0,ARF/MOSF w/Sepsis,14.0,>$50k,220490.0,black,metastatic,0.099999964,0.0009999992,dnr after sadm,5.0,115.0,15.0,55.0,14.0,36.09375,136.65625,2.0,1.0,0.59997559,136.0,7.5,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3061523
51.56699,female,0.0,Cirrhosis,12.0,under $11k,1435423.0,other,no,0.699999809,0.5,no dnr,6.0,58.0,10.5,72.0,24.0,36.0,224.0,2.199707,19.796875,2.09960938,126.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.4399414
55.13998,female,0.0,COPD,12.0,under $11k,7322.0,white,no,0.699999809,0.5,no dnr,4.0,71.0,7.59960938,84.0,20.0,36.79688,223.78125,2.8999023,0.89990234,0.69995117,136.0,7.439453,135.0,23.0,1968.0,1.0,5.0,adl>=4 (>=5 if sur),5.0
30.69099,male,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,138003.0,white,no,0.699999809,0.5,no dnr,19.0,110.0,17.1992188,150.0,45.0,38.69531,357.5,2.8999023,0.89990234,0.59997559,135.0,7.479492,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,2.5795898
47.34799,female,0.0,ARF/MOSF w/Sepsis,12.0,under $11k,23807.0,white,no,0.979999542,0.8999996,no dnr,6.0,77.0,14.2988281,100.0,45.0,38.09375,196.65625,2.8999023,0.59997559,0.59997559,143.0,7.469727,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.4794922
60.23297,male,0.0,Lung Cancer,12.0,under $11k,16410.0,other,metastatic,0.699999809,0.5,dnr after sadm,2.0,79.0,19.8984375,160.0,16.0,36.39844,228.5625,4.1992188,1.29980469,1.79980469,134.0,7.459961,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.3388672
37.08099,male,0.0,Cirrhosis,12.0,under $11k,7547.0,white,no,0.949999809,0.5,no dnr,7.0,105.0,7.59960938,100.0,22.0,38.79688,224.0,2.8999023,6.89941406,0.59997559,133.0,7.419922,135.0,23.0,1968.0,0.0,1.0,<2 mo. follow-up,3.2421875
63.25,male,0.0,Lung Cancer,13.0,$25-$50k,15400.0,asian,metastatic,0.699999809,0.5,no dnr,5.0,87.0,11.1992188,100.0,30.0,38.0,224.0,4.5996094,0.5,0.89990234,134.0,7.419922,135.0,23.0,1968.0,0.0,1.0,no(M2 and SIP pres),1.8708496
51.87698,male,0.0,Lung Cancer,16.0,>$50k,22975.0,white,metastatic,0.699999809,0.5,no dnr,11.0,91.0,3.89990234,100.0,20.0,36.59375,285.6875,2.8999023,0.29998779,0.89990234,133.0,7.519531,135.0,23.0,1968.0,0.0,0.0,no(M2 and SIP pres),0.0
